
and she was deemed suitable for discharge


and constipation
at night p  w generalized weakness and fatigue  urinary incontinence and shaking as well as increased sputum production
and Bipap at night p  w generalized weakness and fatigue  urinary incontinence and shaking as well as increased sputum production
urinary incontinence and shaking as well as increased sputum production
urinary incontinence and shaking as well as increased sputum production
and fatigue  urinary incontinence and shaking as well as increased sputum production
and fatigue  urinary incontinence and shaking as well as increased sputum production

Wheezing NOVOLOG  INSULIN ASPART  4 UNITS SC AC
Wheezing NOVOLOG  INSULIN ASPART  4 UNITS SC AC
4 UNITS SC AC
Wheezing NOVOLOG  INSULIN ASPART  4 UNITS SC AC
Wheezing NOVOLOG  INSULIN ASPART  4 UNITS SC AC
Wheezing NOVOLOG  INSULIN ASPART  4 UNITS SC AC
NOVOLOG  INSULIN ASPART  4 UNITS SC AC
NOVOLOG  INSULIN ASPART  4 UNITS SC AC
4 UNITS SC AC
NOVOLOG  INSULIN ASPART  4 UNITS SC AC
NOVOLOG  INSULIN ASPART  4 UNITS SC AC
NOVOLOG  INSULIN ASPART  4 UNITS SC AC



5
no evidence of failure
lisinopril Pump no evidence of failure

hitis to complete a 5 day course  keep o2 sat 9094  home nocturnal CPAP not tolerated in house  does well on nc  appears ato be at baseline
singulair  spiriva  claritin azithromycin for atypical bronchitis to complete a 5 day course  keep o2 sat 9094  home nocturnal CPAP not tolerated in house  does well on nc  appears ato be at baseline
advair  singulair  spiriva  claritin azithromycin for atypical bronchitis to complete a 5 day course  keep o2 sat 9094  home nocturnal CPAP not tolerated in house  does well on nc  appears ato be at baseline
spiriva  claritin azithromycin for atypical bronchitis to complete a 5 day course  keep o2 sat 9094  home nocturnal CPAP not tolerated in house  does well on nc  appears ato be at baseline
cont prednisone 60  taper slowly as tolerated  duonebs  advair  singulair  spiriva  claritin azithromycin for atypical bronchitis to complete a 5 day course  keep o2 sat 9094  home nocturnal CPAP not tolerated in house  does well on nc  appears ato be at baseline
for atypical bronchitis to complete a 5 day course  keep o2 sat 9094  home nocturnal CPAP not tolerated in house  does well on nc  appears ato be at baseline
azithromycin for atypical bronchitis to complete a 5 day course  keep o2 sat 9094  home nocturnal CPAP not tolerated in house  does well on nc  appears ato be at baseline
60  taper slowly as tolerated  duonebs  advair  singulair  spiriva  claritin azithromycin for atypical bronchitis to complete a 5 day course  keep o2 sat 9094  home nocturnal CPAP not tolerated in house  does well on nc  appears ato be at baseline
claritin azithromycin for atypical bronchitis to complete a 5 day course  keep o2 sat 9094  home nocturnal CPAP not tolerated in house  does well on nc  appears ato be at baseline
not tolerated in house  does well on nc  appears ato be at baseline

for COPD flare
5
with steroids

5
5
at night p  w generalized weakness and fatigue  urinary incontinence and shaking as well as increased sputum production
and Bipap at night p  w generalized weakness and fatigue  urinary incontinence and shaking as well as increased sputum production
LISINOPRIL 10 MG PO DAILY NIFEREX150 150 MG PO BID PREDNISONE Taper PO Give 50 mg q 24 h X 1 dose  s   then Give 40 mg q 24 h X 1 dose  s   then Give 30 mg q 24 h X 1 dose  s   then Give 20 mg q 24 h X 1 dose  s   then Give 10 mg q 24 h X 1 dose  s   then Starting Today  0317  CLARITIN  LORATADINE  10 MG PO DAILY
LISINOPRIL 10 MG PO DAILY NIFEREX150 150 MG PO BID PREDNISONE Taper PO Give 50 mg q 24 h X 1 dose  s   then Give 40 mg q 24 h X 1 dose  s   then Give 30 mg q 24 h X 1 dose  s   then Give 20 mg q 24 h X 1 dose  s   then Give 10 mg q 24 h X 1 dose  s   then Starting Today  0317  CLARITIN  LORATADINE  10 MG PO DAILY
10 MG PO DAILY
10 MG PO DAILY NIFEREX150 150 MG PO BID PREDNISONE Taper PO Give 50 mg q 24 h X 1 dose  s   then Give 40 mg q 24 h X 1 dose  s   then Give 30 mg q 24 h X 1 dose  s   then Give 20 mg q 24 h X 1 dose  s   then Give 10 mg q 24 h X 1 dose  s   then Starting Today  0317  CLARITIN  LORATADINE  10 MG PO DAILY
Give 50 mg q 24 h X 1 dose  s   then Give 40 mg q 24 h X 1 dose  s   then Give 30 mg q 24 h X 1 dose  s   then Give 20 mg q 24 h X 1 dose  s   then Give 10 mg q 24 h X 1 dose  s   then Starting Today  0317  CLARITIN  LORATADINE  10 MG PO DAILY
150 MG PO BID PREDNISONE Taper PO Give 50 mg q 24 h X 1 dose  s   then Give 40 mg q 24 h X 1 dose  s   then Give 30 mg q 24 h X 1 dose  s   then Give 20 mg q 24 h X 1 dose  s   then Give 10 mg q 24 h X 1 dose  s   then Starting Today  0317  CLARITIN  LORATADINE  10 MG PO DAILY
as well as increased sputum production
as well as increased sputum production
hitis to complete a 5 day course  keep o2 sat 9094  home nocturnal CPAP not tolerated in house  does well on nc  appears ato be at baseline
to complete a 5 day course  keep o2 sat 9094  home nocturnal CPAP not tolerated in house  does well on nc  appears ato be at baseline
to complete a 5 day course  keep o2 sat 9094  home nocturnal CPAP not tolerated in house  does well on nc  appears ato be at baseline
to complete a 5 day course  keep o2 sat 9094  home nocturnal CPAP not tolerated in house  does well on nc  appears ato be at baseline
to complete a 5 day course  keep o2 sat 9094  home nocturnal CPAP not tolerated in house  does well on nc  appears ato be at baseline
to complete a 5 day course  keep o2 sat 9094  home nocturnal CPAP not tolerated in house  does well on nc  appears ato be at baseline
to complete a 5 day course  keep o2 sat 9094  home nocturnal CPAP not tolerated in house  does well on nc  appears ato be at baseline
to complete a 5 day course  keep o2 sat 9094  home nocturnal CPAP not tolerated in house  does well on nc  appears ato be at baseline
to complete a 5 day course  keep o2 sat 9094  home nocturnal CPAP not tolerated in house  does well on nc  appears ato be at baseline
not tolerated in house  does well on nc  appears ato be at baseline
and shaking as well as increased sputum production
and shaking as well as increased sputum production
5


5





status post appendectomy
for BPH  total knee replacement  status post appendectomy
prostatectomy for BPH  total knee replacement  status post appendectomy

on po pain medications
in the last two weeks



but at the time of discharge to the rehab facility he was able to control his pain on po pain medications
as well as obtaining issue for a pathologic diagnosis

status post appendectomy
total knee replacement  status post appendectomy
total knee replacement  status post appendectomy

status post appendectomy
for BPH  total knee replacement  status post appendectomy
prostatectomy for BPH  total knee replacement  status post appendectomy


using stulz neuro navigation
using stulz neuro navigation
four to five months ago with the increasing weakness
as well as obtaining issue for a pathologic diagnosis
was placed


status post appendectomy
for BPH  total knee replacement  status post appendectomy
prostatectomy for BPH  total knee replacement  status post appendectomy

status post appendectomy
for BPH  total knee replacement  status post appendectomy
prostatectomy for BPH  total knee replacement  status post appendectomy

two partial hysterectomies  and an appendectomy
including repair of a ureteral stricture  cataract implants  two partial hysterectomies  and an appendectomy
and an appendectomy
of a ureteral stricture  cataract implants  two partial hysterectomies  and an appendectomy
well


two partial hysterectomies  and an appendectomy
cataract implants  two partial hysterectomies  and an appendectomy
and an appendectomy
cataract implants  two partial hysterectomies  and an appendectomy




and the question of CNS metastases

one QD  right eye cataract  operated on three years ago

operated on three years ago
10 PO tid
six weeks ago
to Clonidine six weeks ago
from Aldomet to Clonidine six weeks ago
during his hospital course
and Percodan during his hospital course





on two occasions  on one occasion with prothrombin time 13  and has been replaced by antiplatelet agents

in the past
in the past

could be minimized interventional neuroradiology occlusion of the arteries to the nose bilaterally
of the arteries to the nose bilaterally
could be minimized interventional neuroradiology occlusion of the arteries to the nose bilaterally
of the arteries to the nose bilaterally
from the right neck and right groin on the day of admission

and there was difficulty weaning him off the vent

was consulted but due to the severity of the bleed surgery was not considered an option
and worsening mucositis
and worsening mucositis

and a diffuse erythroderm felt to be a drug reaction
and a diffuse erythroderm felt to be a drug reaction
felt to be a drug reaction



and Nipride intravenously

help
and occupational therapy help
help
and occupational therapy help
help
and occupational therapy help


five times a day

is not spontaneously resolving off of antibiotics

and Ancef for 14 days intravenous  bug being sensitive to these two drugs
for 14 days intravenous  bug being sensitive to these two drugs

being sensitive to these two drugs
being sensitive to these two drugs

from this
recurred on this antibiotic regimen

recurred on this antibiotic regimen



as described  she should not have any problems from this

at this time

Nystatin powder to axilla and groin as needed
to axilla and groin as needed
as described  she should not have any problems from this
which might irritate the liver

in the past




in 0397 while in the hospital for a rib fracture  glaucoma  diabetic retinopathy with blindness in the right eye  history of gastric stapling  left rib fracture  right femur surgery
left rib fracture  right femur surgery

history of gastric stapling  left rib fracture  right femur surgery
left rib fracture  right femur surgery

with blindness in the right eye  history of gastric stapling  left rib fracture  right femur surgery
left rib fracture  right femur surgery

Fournier aposs gangrene versus necrotizing fasciitis  congestive heart failure in 0397 while in the hospital for a rib fracture  glaucoma  diabetic retinopathy with blindness in the right eye  history of gastric stapling  left rib fracture  right femur surgery
left rib fracture  right femur surgery





and glaucoma
and glaucoma
tid

versus necrotizing fasciitis  congestive heart failure in 0397 while in the hospital for a rib fracture  glaucoma  diabetic retinopathy with blindness in the right eye  history of gastric stapling  left rib fracture  right femur surgery
left rib fracture  right femur surgery


diabetic retinopathy with blindness in the right eye  history of gastric stapling  left rib fracture  right femur surgery
left rib fracture  right femur surgery

three vessels in 1987   history of chronic  stable angina pectoris  Fournier aposs gangrene versus necrotizing fasciitis  congestive heart failure in 0397 while in the hospital for a rib fracture  glaucoma  diabetic retinopathy with blindness in the right eye  history of gastric stapling  left rib fracture  right femur surgery
left rib fracture  right femur surgery


during reduction of the fracture
in 1987
congestive heart failure in 0397 while in the hospital for a rib fracture  glaucoma  diabetic retinopathy with blindness in the right eye  history of gastric stapling  left rib fracture  right femur surgery
left rib fracture  right femur surgery

congestive heart failure  who presents with a humeral fracture
in 1987
in 1987
three vessels in 1987   history of chronic  stable angina pectoris  Fournier aposs gangrene versus necrotizing fasciitis  congestive heart failure in 0397 while in the hospital for a rib fracture  glaucoma  diabetic retinopathy with blindness in the right eye  history of gastric stapling  left rib fracture  right femur surgery
left rib fracture  right femur surgery

in 1987
in 0597

the patient was sedated  did not feel chest pain or shortness of breath
who presents with a humeral fracture

during reduction of the fracture


during reduction of the fracture
or shortness of breath
were noted on 101997 to 102097  and the first level was 744  CPK  2 635  and CPK  3 461



right femur surgery
right femur surgery


glaucoma  diabetic retinopathy with blindness in the right eye  history of gastric stapling  left rib fracture  right femur surgery
left rib fracture  right femur surgery


with plans for him to followup with Dr Necessary
for diuresis and his Captopril was increased for greater afterload reduction
was increased for greater afterload reduction

and his Captopril was increased for greater afterload reduction

and started on diuresis with IV Lasix for two days and then switched to an oral Lasix regimen

with IV Lasix for two days and then switched to an oral Lasix regimen
for two days and then switched to an oral Lasix regimen




and Advil

on 41793

on 42293  the patient underwent a duplex ultrasound examination  which showed no evidence of of deep venous thrombosis
level of 24 on the day of admission  he suggested supplementation with potassium

12 TAB PO Q4H PRN PAIN
600 MG PO Q46H PRN PAIN MILK OF MAGNESIA  MAGNESIUM HYDROXIDE  30 MILLILITERS PO QD PRN Constipation PERCOCET 12 TAB PO Q4H PRN PAIN
100 MG PO BID PRN Constipation IBUPROFEN 600 MG PO Q46H PRN PAIN MILK OF MAGNESIA  MAGNESIUM HYDROXIDE  30 MILLILITERS PO QD PRN Constipation PERCOCET 12 TAB PO Q4H PRN PAIN
30 MILLILITERS PO QD PRN Constipation PERCOCET 12 TAB PO Q4H PRN PAIN
COLACE  DOCUSATE SODIUM  100 MG PO BID PRN Constipation IBUPROFEN 600 MG PO Q46H PRN PAIN MILK OF MAGNESIA  MAGNESIUM HYDROXIDE  30 MILLILITERS PO QD PRN Constipation PERCOCET 12 TAB PO Q4H PRN PAIN
COLACE  DOCUSATE SODIUM  100 MG PO BID PRN Constipation IBUPROFEN 600 MG PO Q46H PRN PAIN MILK OF MAGNESIA  MAGNESIUM HYDROXIDE  30 MILLILITERS PO QD PRN Constipation PERCOCET 12 TAB PO Q4H PRN PAIN
COLACE  DOCUSATE SODIUM  100 MG PO BID PRN Constipation IBUPROFEN 600 MG PO Q46H PRN PAIN MILK OF MAGNESIA  MAGNESIUM HYDROXIDE  30 MILLILITERS PO QD PRN Constipation PERCOCET 12 TAB PO Q4H PRN PAIN
COLACE  DOCUSATE SODIUM  100 MG PO BID PRN Constipation IBUPROFEN 600 MG PO Q46H PRN PAIN MILK OF MAGNESIA  MAGNESIUM HYDROXIDE  30 MILLILITERS PO QD PRN Constipation PERCOCET 12 TAB PO Q4H PRN PAIN
COLACE  DOCUSATE SODIUM  100 MG PO BID PRN Constipation IBUPROFEN 600 MG PO Q46H PRN PAIN MILK OF MAGNESIA  MAGNESIUM HYDROXIDE  30 MILLILITERS PO QD PRN Constipation PERCOCET 12 TAB PO Q4H PRN PAIN
COLACE  DOCUSATE SODIUM  100 MG PO BID PRN Constipation IBUPROFEN 600 MG PO Q46H PRN PAIN MILK OF MAGNESIA  MAGNESIUM HYDROXIDE  30 MILLILITERS PO QD PRN Constipation PERCOCET 12 TAB PO Q4H PRN PAIN
12 TAB PO Q4H PRN PAIN
COLACE  DOCUSATE SODIUM  100 MG PO BID PRN Constipation IBUPROFEN 600 MG PO Q46H PRN PAIN MILK OF MAGNESIA  MAGNESIUM HYDROXIDE  30 MILLILITERS PO QD PRN Constipation PERCOCET 12 TAB PO Q4H PRN PAIN
COLACE  DOCUSATE SODIUM  100 MG PO BID PRN Constipation IBUPROFEN 600 MG PO Q46H PRN PAIN MILK OF MAGNESIA  MAGNESIUM HYDROXIDE  30 MILLILITERS PO QD PRN Constipation PERCOCET 12 TAB PO Q4H PRN PAIN
30 MILLILITERS PO QD PRN Constipation PERCOCET 12 TAB PO Q4H PRN PAIN
COLACE  DOCUSATE SODIUM  100 MG PO BID PRN Constipation IBUPROFEN 600 MG PO Q46H PRN PAIN MILK OF MAGNESIA  MAGNESIUM HYDROXIDE  30 MILLILITERS PO QD PRN Constipation PERCOCET 12 TAB PO Q4H PRN PAIN
12 TAB PO Q4H PRN PAIN
IBUPROFEN 600 MG PO Q46H PRN PAIN MILK OF MAGNESIA  MAGNESIUM HYDROXIDE  30 MILLILITERS PO QD PRN Constipation PERCOCET 12 TAB PO Q4H PRN PAIN
IBUPROFEN 600 MG PO Q46H PRN PAIN MILK OF MAGNESIA  MAGNESIUM HYDROXIDE  30 MILLILITERS PO QD PRN Constipation PERCOCET 12 TAB PO Q4H PRN PAIN
IBUPROFEN 600 MG PO Q46H PRN PAIN MILK OF MAGNESIA  MAGNESIUM HYDROXIDE  30 MILLILITERS PO QD PRN Constipation PERCOCET 12 TAB PO Q4H PRN PAIN
IBUPROFEN 600 MG PO Q46H PRN PAIN MILK OF MAGNESIA  MAGNESIUM HYDROXIDE  30 MILLILITERS PO QD PRN Constipation PERCOCET 12 TAB PO Q4H PRN PAIN
12 TAB PO Q4H PRN PAIN
600 MG PO Q46H PRN PAIN MILK OF MAGNESIA  MAGNESIUM HYDROXIDE  30 MILLILITERS PO QD PRN Constipation PERCOCET 12 TAB PO Q4H PRN PAIN
IBUPROFEN 600 MG PO Q46H PRN PAIN MILK OF MAGNESIA  MAGNESIUM HYDROXIDE  30 MILLILITERS PO QD PRN Constipation PERCOCET 12 TAB PO Q4H PRN PAIN
30 MILLILITERS PO QD PRN Constipation PERCOCET 12 TAB PO Q4H PRN PAIN
IBUPROFEN 600 MG PO Q46H PRN PAIN MILK OF MAGNESIA  MAGNESIUM HYDROXIDE  30 MILLILITERS PO QD PRN Constipation PERCOCET 12 TAB PO Q4H PRN PAIN
to decompress his biliary tree
attempt to place percutaneous drains to decompress his biliary tree


without any difficulty


unclear
and gastrointestinal symptoms  Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
and gastrointestinal symptoms  Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
associated with itching and gastrointestinal symptoms  Demerol unclear
and gastrointestinal symptoms  Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
and gastrointestinal symptoms  Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
unclear
Erythromycin  declomycin associated with edema and rash  Talwin associated with disorientation and gastrointestinal symptoms  Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
declomycin associated with edema and rash  Talwin associated with disorientation and gastrointestinal symptoms  Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
associated with itching and gastrointestinal symptoms  Demerol unclear
associated with edema and rash  Talwin associated with disorientation and gastrointestinal symptoms  Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
associated with disorientation and gastrointestinal symptoms  Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
as well as a subtle temporal disc pallor OD  possibly due to previous episode of optic neuritis
unclear
Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
associated with itching and gastrointestinal symptoms  Demerol unclear
Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
possibly due to previous episode of optic neuritis

fibrocystic breast disease  endometriosis and status post total abdominal hysterectomy
unclear
and rash  Talwin associated with disorientation and gastrointestinal symptoms  Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
and rash  Talwin associated with disorientation and gastrointestinal symptoms  Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
associated with itching and gastrointestinal symptoms  Demerol unclear
and rash  Talwin associated with disorientation and gastrointestinal symptoms  Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
and rash  Talwin associated with disorientation and gastrointestinal symptoms  Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
and rash  Talwin associated with disorientation and gastrointestinal symptoms  Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear

unclear
Talwin associated with disorientation and gastrointestinal symptoms  Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
Talwin associated with disorientation and gastrointestinal symptoms  Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
associated with itching and gastrointestinal symptoms  Demerol unclear
Talwin associated with disorientation and gastrointestinal symptoms  Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
Talwin associated with disorientation and gastrointestinal symptoms  Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
Talwin associated with disorientation and gastrointestinal symptoms  Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
unclear
Talwin associated with disorientation and gastrointestinal symptoms  Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
Talwin associated with disorientation and gastrointestinal symptoms  Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
associated with itching and gastrointestinal symptoms  Demerol unclear
Talwin associated with disorientation and gastrointestinal symptoms  Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
associated with disorientation and gastrointestinal symptoms  Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
unchanged at the time of discharge
unclear
and rash  Talwin associated with disorientation and gastrointestinal symptoms  Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
and rash  Talwin associated with disorientation and gastrointestinal symptoms  Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
associated with itching and gastrointestinal symptoms  Demerol unclear
and rash  Talwin associated with disorientation and gastrointestinal symptoms  Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
associated with disorientation and gastrointestinal symptoms  Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
unclear
and gastrointestinal symptoms  Demerol unclear
and gastrointestinal symptoms  Demerol unclear
and gastrointestinal symptoms  Demerol unclear
and gastrointestinal symptoms  Demerol unclear
and gastrointestinal symptoms  Demerol unclear
and gastrointestinal symptoms  Demerol unclear
unclear
Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
Dilantin has caused rash and edema  morphine associated with itching and gastrointestinal symptoms  Demerol unclear
endometriosis and status post total abdominal hysterectomy

in the past only once for a surgical repair of trigeminal neuralgia
and status post total abdominal hysterectomy
50  no refills


DOCUSATE SODIUM 100 MG PO BID PRN Constipation IBUPROFEN 400600 MG PO Q6H PRN Pain
400600 MG PO Q6H PRN Pain
100 MG PO BID PRN Constipation IBUPROFEN 400600 MG PO Q6H PRN Pain


DOCUSATE SODIUM 100 MG PO BID PRN Constipation IBUPROFEN 400600 MG PO Q6H PRN Pain
DOCUSATE SODIUM 100 MG PO BID PRN Constipation IBUPROFEN 400600 MG PO Q6H PRN Pain
DOCUSATE SODIUM 100 MG PO BID PRN Constipation IBUPROFEN 400600 MG PO Q6H PRN Pain
IBUPROFEN 400600 MG PO Q6H PRN Pain
400600 MG PO Q6H PRN Pain
IBUPROFEN 400600 MG PO Q6H PRN Pain

which is apparently working well





ALDOMET  METHYLDOPA  250 MG PO BID PERCOCET 12 TAB PO Q4H PRN PAIN
ALDOMET  METHYLDOPA  250 MG PO BID PERCOCET 12 TAB PO Q4H PRN PAIN
ALDOMET  METHYLDOPA  250 MG PO BID PERCOCET 12 TAB PO Q4H PRN PAIN
ALDOMET  METHYLDOPA  250 MG PO BID PERCOCET 12 TAB PO Q4H PRN PAIN
for the next few days
please take with food in your stomach
and an abnormal EEG
and an abnormal EEG
and an abnormal EEG

and an abnormal EEG

and an abnormal EEG
IBUPROFEN 400600 MG PO Q6H PRN Pain
400600 MG PO Q6H PRN Pain







and Levofloxacin
who was transferred from Child for worsening cellulitis and new confusion

and new confusion

and Levofloxacin
or her metabolic condition
or her metabolic condition






well
was
adenoidectomy  vein stripping  1968   left wrist fracture  1994   and hypercholesterolemia
1968   left wrist fracture  1994   and hypercholesterolemia
vein stripping  1968   left wrist fracture  1994   and hypercholesterolemia








adenoidectomy  vein stripping  1968   left wrist fracture  1994   and hypercholesterolemia
1968   left wrist fracture  1994   and hypercholesterolemia
vein stripping  1968   left wrist fracture  1994   and hypercholesterolemia
adenoidectomy  vein stripping  1968   left wrist fracture  1994   and hypercholesterolemia
1968   left wrist fracture  1994   and hypercholesterolemia
vein stripping  1968   left wrist fracture  1994   and hypercholesterolemia
well


was changed to Ancef
adenoidectomy  vein stripping  1968   left wrist fracture  1994   and hypercholesterolemia
1968   left wrist fracture  1994   and hypercholesterolemia
vein stripping  1968   left wrist fracture  1994   and hypercholesterolemia
adenoidectomy  vein stripping  1968   left wrist fracture  1994   and hypercholesterolemia
1968   left wrist fracture  1994   and hypercholesterolemia
vein stripping  1968   left wrist fracture  1994   and hypercholesterolemia
1994   and hypercholesterolemia
1994   and hypercholesterolemia
1994   and hypercholesterolemia
adenoidectomy  vein stripping  1968   left wrist fracture  1994   and hypercholesterolemia
1968   left wrist fracture  1994   and hypercholesterolemia
vein stripping  1968   left wrist fracture  1994   and hypercholesterolemia
associated with confusion






on proximal greater than distal musculature

at some time in the near future



and therefore the surgery was canceled
was canceled
32594

in 1988  chronic atrial fibrillation  hypertension  who presents for parathyroidectomy



who presents for parathyroidectomy

hypertension  who presents for parathyroidectomy

Nifedipine and Percocet
ace inhibitors  Nifedipine and Percocet

codeine  ace inhibitors  Nifedipine and Percocet
and Percocet
with spasticity  occasional difficulty swallowing and abdominal pain

tetracycline and Bactrim
and Bactrim

gentamycin  nitrofurantoin  tetracycline and Bactrim
nitrofurantoin  tetracycline and Bactrim


and adequate analgesia
including Baclofen  Valium and adequate analgesia
including Baclofen  Valium and adequate analgesia
Valium and adequate analgesia
including Baclofen  Valium and adequate analgesia
and pain with spasticity  occasional difficulty swallowing and abdominal pain
occasional difficulty swallowing and abdominal pain
and abdominal pain
Insulin by sliding scale and levofloxacin 500 mg qd
500 mg qd
by sliding scale and levofloxacin 500 mg qd

and adequate analgesia
with optimization of pharmacological regimen for spasticity including Baclofen  Valium and adequate analgesia
for spasticity including Baclofen  Valium and adequate analgesia
Valium and adequate analgesia
with optimization of pharmacological regimen for spasticity including Baclofen  Valium and adequate analgesia


consistent with prior surgical intervention







which had been recently stopped anyway

and gram negative rods
and gram negative rods



could be a cause of these abnormalities
could be a cause of these abnormalities



could be a cause of these abnormalities
of both
of both
10 mg po q6h prn nausea  Decadron 20 mg po q6h x 2 doses
20 mg po q6h x 2 doses
Compazine 10 mg po q6h prn nausea  Decadron 20 mg po q6h x 2 doses
Compazine 10 mg po q6h prn nausea  Decadron 20 mg po q6h x 2 doses
Compazine 10 mg po q6h prn nausea  Decadron 20 mg po q6h x 2 doses
lead her to initial consultation with Dr Lentny Farstnappsshee in Gobrew Street  Denlandcobridclevena  West Virginia 28880


in 1979  cholecystectomy in 1986
in 1986
in 1979  cholecystectomy in 1986
from surface of transverse colon
from surface of transverse colon
from surface of transverse colon
from surface of transverse colon
from surface of transverse colon
from surface of transverse colon
with no relief  a nasogastric tube was placed which drained 1200 cc of bilious fluid
was placed which drained 1200 cc of bilious fluid
with no relief  a nasogastric tube was placed which drained 1200 cc of bilious fluid
was placed which drained 1200 cc of bilious fluid
a nasogastric tube was placed which drained 1200 cc of bilious fluid
was placed which drained 1200 cc of bilious fluid
removal of mass from surface of transverse colon
removal of mass from surface of transverse colon
of mass from surface of transverse colon
removal of mass from surface of transverse colon
removal of mass from surface of transverse colon
removal of mass from surface of transverse colon
Compazine 10 mg po q6h prn nausea  Decadron 20 mg po q6h x 2 doses
20 mg po q6h x 2 doses
Compazine 10 mg po q6h prn nausea  Decadron 20 mg po q6h x 2 doses
Compazine 10 mg po q6h prn nausea  Decadron 20 mg po q6h x 2 doses
Compazine 10 mg po q6h prn nausea  Decadron 20 mg po q6h x 2 doses
and urinary symptoms lead her to initial consultation with Dr Lentny Farstnappsshee in Gobrew Street  Denlandcobridclevena  West Virginia 28880
10 mg po q6h prn nausea  Decadron 20 mg po q6h x 2 doses
20 mg po q6h x 2 doses
Zofran 8 mg po q8h prn nausea  Compazine 10 mg po q6h prn nausea  Decadron 20 mg po q6h x 2 doses
Zofran 8 mg po q8h prn nausea  Compazine 10 mg po q6h prn nausea  Decadron 20 mg po q6h x 2 doses
8 mg po q8h prn nausea  Compazine 10 mg po q6h prn nausea  Decadron 20 mg po q6h x 2 doses
obesity  history of heart murmur  hemorrhoids and whooping cough as a child
obesity  history of heart murmur  hemorrhoids and whooping cough as a child
10 mg po q6h prn nausea  Decadron 20 mg po q6h x 2 doses
20 mg po q6h x 2 doses
Ativan 1 mg po q12h prn anxiety  Zofran 8 mg po q8h prn nausea  Compazine 10 mg po q6h prn nausea  Decadron 20 mg po q6h x 2 doses
1 mg po q12h prn anxiety  Zofran 8 mg po q8h prn nausea  Compazine 10 mg po q6h prn nausea  Decadron 20 mg po q6h x 2 doses
8 mg po q8h prn nausea  Compazine 10 mg po q6h prn nausea  Decadron 20 mg po q6h x 2 doses
removal of mass from surface of transverse colon
of mass from surface of transverse colon
removal of mass from surface of transverse colon
removal of mass from surface of transverse colon
removal of mass from surface of transverse colon
removal of mass from surface of transverse colon
as a child
history of heart murmur  hemorrhoids and whooping cough as a child
possibly serous carcinoma of the ovary
hemorrhoids and whooping cough as a child

from surface of transverse colon
from surface of transverse colon
from surface of transverse colon
from surface of transverse colon
from surface of transverse colon
from surface of transverse colon
and whooping cough as a child


and asthma symptoms
and asthma symptoms


magnesium sulfate  sliding scale IV and potassium chloride  sliding scale IV
sliding scale IV and potassium chloride  sliding scale IV
sliding scale IV







was placed there on December 29



KBL mouthwash  15 ccp o
15 ccp o
regular sliding scale insulin  KBL mouthwash  15 ccp o
with morphine for breakthrough pain
for breakthrough pain


only








with instructions to use caution
with instructions to use caution
with instructions to continue until bowel movement and then decrease to bid
Ativan  025 to 05 mg IV q 4 to 6 hours prn anxiety with instructions to use caution
025 to 05 mg IV q 4 to 6 hours prn anxiety with instructions to use caution

decompensated with pulmonary edema  requiring both albumin and Lasix to try to mobilize third space fluids
to try to mobilize third space fluids
and Lasix to try to mobilize third space fluids





and will be maintained on Lovenox
bid
also Sarna  topical cream  bid

requiring both albumin and Lasix to try to mobilize third space fluids
to try to mobilize third space fluids
and Lasix to try to mobilize third space fluids
decompensated with pulmonary edema  requiring both albumin and Lasix to try to mobilize third space fluids
to try to mobilize third space fluids
and Lasix to try to mobilize third space fluids
in his lungs from his hypoalbunemic state

30 ml po
Lactulose  30 ml po
decompensated with pulmonary edema  requiring both albumin and Lasix to try to mobilize third space fluids
to try to mobilize third space fluids
and Lasix to try to mobilize third space fluids


ECHO 0289 nl ETT 0389  0790 c  w ND ische
for full course  26 more days
1294    ischemia ECHO 0289 nl ETT 0389  0790 c  w ND ische
1294    ischemia ECHO 0289 nl ETT 0389  0790 c  w ND ische

1294    ischemia ECHO 0289 nl ETT 0389  0790 c  w ND ische


1294    ischemia ECHO 0289 nl ETT 0389  0790 c  w ND ische
and left lobe 6 mm
and left lobe 6 mm
history of Droperidol allergy
asthma  migraine  history of Droperidol allergy

migraine  history of Droperidol allergy
Hiv Counseled
VAGINA NORMAL sml amt thin white d  c ph 45  koh +amine  NS +clue  neg trich CERVIX NORMAL 11000 srom clear OS NORMAL closed ADNEXAE NORMAL no palp masses  NT UTERUS NORMAL gravid UTERINE SIZE IN WEEKS NORMAL term RECTUM NORMAL no ext lesions
CHEST NORMAL LCTA COR NORMAL RRR ABDOMEN NORMAL gravid EXTREM NORMAL SKIN NORMAL NODES NORMAL VULVA NORMAL no lesions  white d  c at introitus VAGINA NORMAL sml amt thin white d  c ph 45  koh +amine  NS +clue  neg trich CERVIX NORMAL 11000 srom clear OS NORMAL closed ADNEXAE NORMAL no palp masses  NT UTERUS NORMAL gravid UTERINE SIZE IN WEEKS NORMAL term RECTUM NORMAL no ext lesions
CHEST NORMAL LCTA COR NORMAL RRR ABDOMEN NORMAL gravid EXTREM NORMAL SKIN NORMAL NODES NORMAL VULVA NORMAL no lesions  white d  c at introitus VAGINA NORMAL sml amt thin white d  c ph 45  koh +amine  NS +clue  neg trich CERVIX NORMAL 11000 srom clear OS NORMAL closed ADNEXAE NORMAL no palp masses  NT UTERUS NORMAL gravid UTERINE SIZE IN WEEKS NORMAL term RECTUM NORMAL no ext lesions

white d  c at introitus VAGINA NORMAL sml amt thin white d  c ph 45  koh +amine  NS +clue  neg trich CERVIX NORMAL 11000 srom clear OS NORMAL closed ADNEXAE NORMAL no palp masses  NT UTERUS NORMAL gravid UTERINE SIZE IN WEEKS NORMAL term RECTUM NORMAL no ext lesions

NT UTERUS NORMAL gravid UTERINE SIZE IN WEEKS NORMAL term RECTUM NORMAL no ext lesions
Hiv Counseled
ph 45  koh +amine  NS +clue  neg trich CERVIX NORMAL 11000 srom clear OS NORMAL closed ADNEXAE NORMAL no palp masses  NT UTERUS NORMAL gravid UTERINE SIZE IN WEEKS NORMAL term RECTUM NORMAL no ext lesions
clear OS NORMAL closed ADNEXAE NORMAL no palp masses  NT UTERUS NORMAL gravid UTERINE SIZE IN WEEKS NORMAL term RECTUM NORMAL no ext lesions






which could be controlled with oral analgesics




and noticed some blood at the site of the catheter
of the catheter


in the past


while in the Intensive Care Unit for prophylaxis against peptic ulcer disease
against peptic ulcer disease



improved

or gastroesophageal reflux disease



presbylaryngis

osteoporosis  presbylaryngis

and slight troponin and MB leak
FEV1 25   chronic pericardial effusion  PVD  R renal artery stenosis  osteoporosis  presbylaryngis
R renal artery stenosis  osteoporosis  presbylaryngis
PVD  R renal artery stenosis  osteoporosis  presbylaryngis
5070 durin enzyme leak







for the next few days











with a greater than 10 loss in the initial gain following coronary angioplasty

with a greater than 10 loss in the initial gain following coronary angioplasty
following coronary angioplasty

following coronary angioplasty


on 080393
and then a permanent pacemaker implantation on 080393
on 080393
and then a permanent pacemaker implantation on 080393
with a peak CPK of 9379 units with a 59 MB fraction
each time with improvement
from lab studies done at the outside hospital
from lab studies done at the outside hospital


potassium sliding scale today  morphine sulfate IV prn
500 mg IV q6h  insulin NPH 60 units subcu q am  insulin NPH 20 units subcu q pm  insulin CZI sliding scale regular  Synthroid 125 mcg po q day  magnesium sliding scale  potassium sliding scale today  morphine sulfate IV prn
today  morphine sulfate IV prn
prn
125 mcg po q day  magnesium sliding scale  potassium sliding scale today  morphine sulfate IV prn
Imipenem 500 mg IV q6h  insulin NPH 60 units subcu q am  insulin NPH 20 units subcu q pm  insulin CZI sliding scale regular  Synthroid 125 mcg po q day  magnesium sliding scale  potassium sliding scale today  morphine sulfate IV prn
Synthroid 125 mcg po q day  magnesium sliding scale  potassium sliding scale today  morphine sulfate IV prn
60 units subcu q am  insulin NPH 20 units subcu q pm  insulin CZI sliding scale regular  Synthroid 125 mcg po q day  magnesium sliding scale  potassium sliding scale today  morphine sulfate IV prn
60 units subcu q am  insulin NPH 20 units subcu q pm  insulin CZI sliding scale regular  Synthroid 125 mcg po q day  magnesium sliding scale  potassium sliding scale today  morphine sulfate IV prn
IV  Dopamine 12 mcg per minute
12 mcg per minute


and requires parenteral morphine sulfate for pain control during dressing changes
for pain control during dressing changes


Carafate 1 gm po qid
Carafate 1 gm po qid
1 gm po qid
or increasing pulmonary edema

and Tobramycin



was noticeably increased
his O2 saturations have improved and he is now on nasal cannula and will be maintained on nasal cannula to keep his sat above 93
and will be maintained on nasal cannula to keep his sat above 93
and will be maintained on nasal cannula to keep his sat above 93



but the right lower extremity swelling was noticeably increased
improved





Ceftriaxone  Mezlocillin  Bactrim  Ampicillin  chloramphenicol  and sulbactam
Mezlocillin  Bactrim  Ampicillin  chloramphenicol  and sulbactam
Tobramycin but was resistant to Cefotetan  Ceftriaxone  Mezlocillin  Bactrim  Ampicillin  chloramphenicol  and sulbactam
Ciprofloxacin  Tobramycin but was resistant to Cefotetan  Ceftriaxone  Mezlocillin  Bactrim  Ampicillin  chloramphenicol  and sulbactam
Bactrim  Ampicillin  chloramphenicol  and sulbactam
Ceftazidime  Amikacin  gentamicin  Ciprofloxacin  Tobramycin but was resistant to Cefotetan  Ceftriaxone  Mezlocillin  Bactrim  Ampicillin  chloramphenicol  and sulbactam
but was resistant to Cefotetan  Ceftriaxone  Mezlocillin  Bactrim  Ampicillin  chloramphenicol  and sulbactam
Amikacin  gentamicin  Ciprofloxacin  Tobramycin but was resistant to Cefotetan  Ceftriaxone  Mezlocillin  Bactrim  Ampicillin  chloramphenicol  and sulbactam
chloramphenicol  and sulbactam
and sulbactam

Ampicillin  chloramphenicol  and sulbactam
gentamicin  Ciprofloxacin  Tobramycin but was resistant to Cefotetan  Ceftriaxone  Mezlocillin  Bactrim  Ampicillin  chloramphenicol  and sulbactam






PERCOCET 12 TAB PO Q4H PRN PAIN
12 TAB PO Q4H PRN PAIN





on 11391


and multivitamins


of the pregnancy
and termination of the pregnancy



to 24 and he was transfused two units of packed red blood cells
transferred to Retelk County Medical Center for further management

transferred to Retelk County Medical Center for further management

failed to improve
failed to improve
was placed




150 milligrams po
Niferex 150 milligrams po



which was administered shortly after
Milk of Magnesia by mouth 30 ml once a day as needed for constipation  Asacol by mouth 400 mg every morning  Asacol 800 mg every night  Lopressor by mouth 25 mg twice a day  Miracle cream topically on skin once a day  nystatin swish and swallow by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
Milk of Magnesia by mouth 30 ml once a day as needed for constipation  Asacol by mouth 400 mg every morning  Asacol 800 mg every night  Lopressor by mouth 25 mg twice a day  Miracle cream topically on skin once a day  nystatin swish and swallow by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
over one hour
by mouth 400 mg every morning  Asacol 800 mg every night  Lopressor by mouth 25 mg twice a day  Miracle cream topically on skin once a day  nystatin swish and swallow by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
topically on skin once a day  nystatin swish and swallow by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
by mouth 400 mg every morning  Asacol 800 mg every night  Lopressor by mouth 25 mg twice a day  Miracle cream topically on skin once a day  nystatin swish and swallow by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
Milk of Magnesia by mouth 30 ml once a day as needed for constipation  Asacol by mouth 400 mg every morning  Asacol 800 mg every night  Lopressor by mouth 25 mg twice a day  Miracle cream topically on skin once a day  nystatin swish and swallow by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
by mouth 30 ml once a day as needed for constipation  Asacol by mouth 400 mg every morning  Asacol 800 mg every night  Lopressor by mouth 25 mg twice a day  Miracle cream topically on skin once a day  nystatin swish and swallow by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
Milk of Magnesia by mouth 30 ml once a day as needed for constipation  Asacol by mouth 400 mg every morning  Asacol 800 mg every night  Lopressor by mouth 25 mg twice a day  Miracle cream topically on skin once a day  nystatin swish and swallow by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
by mouth 25 mg twice a day  Miracle cream topically on skin once a day  nystatin swish and swallow by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour

with bypass grafting
and radiation six years ago  and is an insulindependent diabetic
six years ago  and is an insulindependent diabetic
to vancomycin and levofloxacin
desensitization in the surgical Intensive Care Unit followed by a change of antibiotics to vancomycin and levofloxacin

in the surgical Intensive Care Unit followed by a change of antibiotics to vancomycin and levofloxacin
and Staphylococcus in the wound
and Staphylococcus in the wound
and Staphylococcus in the wound



in the wound
in the wound
in the wound
by mouth 15 ml every six hours as needed for indigestion  Milk of Magnesia by mouth 30 ml once a day as needed for constipation  Asacol by mouth 400 mg every morning  Asacol 800 mg every night  Lopressor by mouth 25 mg twice a day  Miracle cream topically on skin once a day  nystatin swish and swallow by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
by mouth 80 mg every morning  insulin regular according to insulin scale  Synthroid by mouth 25 mcg once a day  Maalox Plus Extra Strength by mouth 15 ml every six hours as needed for indigestion  Milk of Magnesia by mouth 30 ml once a day as needed for constipation  Asacol by mouth 400 mg every morning  Asacol 800 mg every night  Lopressor by mouth 25 mg twice a day  Miracle cream topically on skin once a day  nystatin swish and swallow by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
over one hour
by mouth 400 mg every morning  Asacol 800 mg every night  Lopressor by mouth 25 mg twice a day  Miracle cream topically on skin once a day  nystatin swish and swallow by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
topically on skin once a day  nystatin swish and swallow by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
Lasix by mouth 80 mg every morning  insulin regular according to insulin scale  Synthroid by mouth 25 mcg once a day  Maalox Plus Extra Strength by mouth 15 ml every six hours as needed for indigestion  Milk of Magnesia by mouth 30 ml once a day as needed for constipation  Asacol by mouth 400 mg every morning  Asacol 800 mg every night  Lopressor by mouth 25 mg twice a day  Miracle cream topically on skin once a day  nystatin swish and swallow by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
by mouth 400 mg every morning  Asacol 800 mg every night  Lopressor by mouth 25 mg twice a day  Miracle cream topically on skin once a day  nystatin swish and swallow by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
regular according to insulin scale  Synthroid by mouth 25 mcg once a day  Maalox Plus Extra Strength by mouth 15 ml every six hours as needed for indigestion  Milk of Magnesia by mouth 30 ml once a day as needed for constipation  Asacol by mouth 400 mg every morning  Asacol 800 mg every night  Lopressor by mouth 25 mg twice a day  Miracle cream topically on skin once a day  nystatin swish and swallow by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
by mouth 30 ml once a day as needed for constipation  Asacol by mouth 400 mg every morning  Asacol 800 mg every night  Lopressor by mouth 25 mg twice a day  Miracle cream topically on skin once a day  nystatin swish and swallow by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
by mouth 25 mcg once a day  Maalox Plus Extra Strength by mouth 15 ml every six hours as needed for indigestion  Milk of Magnesia by mouth 30 ml once a day as needed for constipation  Asacol by mouth 400 mg every morning  Asacol 800 mg every night  Lopressor by mouth 25 mg twice a day  Miracle cream topically on skin once a day  nystatin swish and swallow by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
by mouth 25 mg twice a day  Miracle cream topically on skin once a day  nystatin swish and swallow by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour

hypertension  hypothyroidism  congestive heart failure  and coronary artery disease with bypass grafting

hypothyroidism  congestive heart failure  and coronary artery disease with bypass grafting

hypertension  hypothyroidism  congestive heart failure  and coronary artery disease with bypass grafting

congestive heart failure  and coronary artery disease with bypass grafting
which persists up until now and is of a size 2 x 1 cm
which persists up until now and is of a size 2 x 1 cm
and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
over one hour
and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
Lasix by mouth 80 mg every morning  insulin regular according to insulin scale  Synthroid by mouth 25 mcg once a day  Maalox Plus Extra Strength by mouth 15 ml every six hours as needed for indigestion  Milk of Magnesia by mouth 30 ml once a day as needed for constipation  Asacol by mouth 400 mg every morning  Asacol 800 mg every night  Lopressor by mouth 25 mg twice a day  Miracle cream topically on skin once a day  nystatin swish and swallow by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
Lasix by mouth 80 mg every morning  insulin regular according to insulin scale  Synthroid by mouth 25 mcg once a day  Maalox Plus Extra Strength by mouth 15 ml every six hours as needed for indigestion  Milk of Magnesia by mouth 30 ml once a day as needed for constipation  Asacol by mouth 400 mg every morning  Asacol 800 mg every night  Lopressor by mouth 25 mg twice a day  Miracle cream topically on skin once a day  nystatin swish and swallow by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
over one hour
by mouth 400 mg every morning  Asacol 800 mg every night  Lopressor by mouth 25 mg twice a day  Miracle cream topically on skin once a day  nystatin swish and swallow by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
topically on skin once a day  nystatin swish and swallow by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
by mouth 400 mg every morning  Asacol 800 mg every night  Lopressor by mouth 25 mg twice a day  Miracle cream topically on skin once a day  nystatin swish and swallow by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
Lasix by mouth 80 mg every morning  insulin regular according to insulin scale  Synthroid by mouth 25 mcg once a day  Maalox Plus Extra Strength by mouth 15 ml every six hours as needed for indigestion  Milk of Magnesia by mouth 30 ml once a day as needed for constipation  Asacol by mouth 400 mg every morning  Asacol 800 mg every night  Lopressor by mouth 25 mg twice a day  Miracle cream topically on skin once a day  nystatin swish and swallow by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
Lasix by mouth 80 mg every morning  insulin regular according to insulin scale  Synthroid by mouth 25 mcg once a day  Maalox Plus Extra Strength by mouth 15 ml every six hours as needed for indigestion  Milk of Magnesia by mouth 30 ml once a day as needed for constipation  Asacol by mouth 400 mg every morning  Asacol 800 mg every night  Lopressor by mouth 25 mg twice a day  Miracle cream topically on skin once a day  nystatin swish and swallow by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
Lasix by mouth 80 mg every morning  insulin regular according to insulin scale  Synthroid by mouth 25 mcg once a day  Maalox Plus Extra Strength by mouth 15 ml every six hours as needed for indigestion  Milk of Magnesia by mouth 30 ml once a day as needed for constipation  Asacol by mouth 400 mg every morning  Asacol 800 mg every night  Lopressor by mouth 25 mg twice a day  Miracle cream topically on skin once a day  nystatin swish and swallow by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
by mouth 25 mg twice a day  Miracle cream topically on skin once a day  nystatin swish and swallow by mouth 5 ml four times a day  Percocet by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour
by mouth one tab every four hours as needed for pain  and vancomycin by infusion 1 gm every 18 hours  instructions in 250 ml slow IV infusion over one hour



and coronary artery disease with bypass grafting

hypertension  hypothyroidism  congestive heart failure  and coronary artery disease with bypass grafting

hypertension  hypothyroidism  congestive heart failure  and coronary artery disease with bypass grafting
Tylenol  Clinoril  Biaxin  Codeine  Sulfa and Aminophylline

Codeine  Sulfa and Aminophylline
Sulfa and Aminophylline
Biaxin  Codeine  Sulfa and Aminophylline
Clinoril  Biaxin  Codeine  Sulfa and Aminophylline
and Aminophylline
and she has been doing well since  although at baseline now she is minimally ambulatory from bed to commode
bid
and left lung fibrosis  status post methicillin resistant Staphylococcus aureus pneumonia
and left lung fibrosis  status post methicillin resistant Staphylococcus aureus pneumonia
and left lung fibrosis  status post methicillin resistant Staphylococcus aureus pneumonia
for several days after which time her erythema again began to decrease






status post goiter and left lung fibrosis  status post methicillin resistant Staphylococcus aureus pneumonia
status post hysterectomy  status post goiter and left lung fibrosis  status post methicillin resistant Staphylococcus aureus pneumonia
and status post cholecystectomy  status post hysterectomy  status post goiter and left lung fibrosis  status post methicillin resistant Staphylococcus aureus pneumonia

again began to decrease
status post goiter and left lung fibrosis  status post methicillin resistant Staphylococcus aureus pneumonia
status post hysterectomy  status post goiter and left lung fibrosis  status post methicillin resistant Staphylococcus aureus pneumonia
and status post cholecystectomy  status post hysterectomy  status post goiter and left lung fibrosis  status post methicillin resistant Staphylococcus aureus pneumonia

with 6 millimeter PTFE
status post goiter and left lung fibrosis  status post methicillin resistant Staphylococcus aureus pneumonia
status post hysterectomy  status post goiter and left lung fibrosis  status post methicillin resistant Staphylococcus aureus pneumonia
and status post cholecystectomy  status post hysterectomy  status post goiter and left lung fibrosis  status post methicillin resistant Staphylococcus aureus pneumonia



status post goiter and left lung fibrosis  status post methicillin resistant Staphylococcus aureus pneumonia
status post hysterectomy  status post goiter and left lung fibrosis  status post methicillin resistant Staphylococcus aureus pneumonia
and status post cholecystectomy  status post hysterectomy  status post goiter and left lung fibrosis  status post methicillin resistant Staphylococcus aureus pneumonia
at night
at that time
status post methicillin resistant Staphylococcus aureus pneumonia
status post methicillin resistant Staphylococcus aureus pneumonia
status post methicillin resistant Staphylococcus aureus pneumonia
from bed to commode







and Flecainide were used  but were stopped because of intolerance
Norpace  Corgard  and Flecainide were used  but were stopped because of intolerance
Corgard  and Flecainide were used  but were stopped because of intolerance
Procainamide  Tenormin  Norpace  Corgard  and Flecainide were used  but were stopped because of intolerance
Quinidine  Procainamide  Tenormin  Norpace  Corgard  and Flecainide were used  but were stopped because of intolerance
were used  but were stopped because of intolerance
Tenormin  Norpace  Corgard  and Flecainide were used  but were stopped because of intolerance
and Flecainide were used  but were stopped because of intolerance
Norpace  Corgard  and Flecainide were used  but were stopped because of intolerance
Corgard  and Flecainide were used  but were stopped because of intolerance
Procainamide  Tenormin  Norpace  Corgard  and Flecainide were used  but were stopped because of intolerance
Quinidine  Procainamide  Tenormin  Norpace  Corgard  and Flecainide were used  but were stopped because of intolerance
were used  but were stopped because of intolerance
Tenormin  Norpace  Corgard  and Flecainide were used  but were stopped because of intolerance

and mild shortness of breath


with a rapid ventricular rate after several days of decreased exercise tolerance

after several days of decreased exercise tolerance








well controlled on oral pain medications  she was discharged to rehabilitation facility
she was discharged to rehabilitation facility
well controlled on oral pain medications  she was discharged to rehabilitation facility
status post appendectomy  and hypertension
and hypertension















sp right facial plating

sp right facial plating

secondary to GSW to face right nephrectomy

to face right nephrectomy

repair
removed without incident
no driving for 1 month no lifting  10  for 10 weeks
no driving for 1 month no lifting  10  for 10 weeks
no driving for 1 month no lifting  10  for 10 weeks

with temp 1012


nor would she be a good candidate for coumadin
or shortness of breath

prior to going to rehab


or wheezing


or shortness of breath

resolved he was transitioned to enteral feeds


to protect the infant

or bradycardic events
once they reach six months of age




at 3067 weeks gestation to a 29yearold gravida 3  para 0 now 1 mother
procedures in 2007 and 1998










and stop showering until the drainage subsides for at least 2 days
subsides for at least 2 days
and stop showering until the drainage subsides for at least 2 days




in 1977
in 1977




and Ativan around the clock for delirium tremens prophylaxis
around the clock for delirium tremens prophylaxis
and a strong adequate cough





except postoperatively  his voice was hoarse
extending deep to the margin as well as positive level II nodes

by Dr Langhorne and split thickness and full thickness skin grafting of the defects on 20160314
of the defects on 20160314

for non Hodgkin s lymphoma  chronic painless hematuria  degenerative joint disease and history of a murmur
for non Hodgkin s lymphoma  chronic painless hematuria  degenerative joint disease and history of a murmur
and history of a murmur
degenerative joint disease and history of a murmur


on 20160314
on 20160314
chronic painless hematuria  degenerative joint disease and history of a murmur
for non Hodgkin s lymphoma  chronic painless hematuria  degenerative joint disease and history of a murmur

began  hepain was dc d
50 after infusion began  hepain was dc d
was dc d
RUE DVT  HIT positive
prior to CT scan
and steroids prior to CT scan
prior to CT scan
and steroids prior to CT scan
prior to CT scan
and steroids prior to CT scan
prior to CT scan
and steroids prior to CT scan

HIT positive

x3

















to boost her blood pressure to 9960  however the patient was admitted to the Medical Intensive Care Unit for overnight observation because of her somnolence and hypotension
at that point with blood pressure of 7045 and received a normal saline bolus to boost her blood pressure to 9960  however the patient was admitted to the Medical Intensive Care Unit for overnight observation because of her somnolence and hypotension
when taking uncoated aspirin

and dyspepsia when taking uncoated aspirin







as well as the presence of her basilar artery stenosis

10 mg daily





and hypotension
and hypotension


times three in 2009 at Clinton Hospital  the patient is status post percutaneous transluminal coronary angioplasty times two in 2005 at WalthamWeston Hospital
times three in 2009 at Clinton Hospital  the patient is status post percutaneous transluminal coronary angioplasty times two in 2005 at WalthamWeston Hospital
times two  who presented with acute coronary syndrome refractory to medical treatment and TNK  now status post AngioJet percutaneous transluminal coronary angioplasty and stent of proximal left anterior descending artery and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement
and TNK  now status post AngioJet percutaneous transluminal coronary angioplasty and stent of proximal left anterior descending artery and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement

times two  who presented with acute coronary syndrome refractory to medical treatment and TNK  now status post AngioJet percutaneous transluminal coronary angioplasty and stent of proximal left anterior descending artery and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement
and stent of proximal left anterior descending artery and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement
now status post AngioJet percutaneous transluminal coronary angioplasty and stent of proximal left anterior descending artery and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement
and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement
refractory to medical treatment and TNK  now status post AngioJet percutaneous transluminal coronary angioplasty and stent of proximal left anterior descending artery and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement
and TNK  now status post AngioJet percutaneous transluminal coronary angioplasty and stent of proximal left anterior descending artery and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement

times two  who presented with acute coronary syndrome refractory to medical treatment and TNK  now status post AngioJet percutaneous transluminal coronary angioplasty and stent of proximal left anterior descending artery and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement
and stent of proximal left anterior descending artery and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement
now status post AngioJet percutaneous transluminal coronary angioplasty and stent of proximal left anterior descending artery and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement
and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement
but without resolution of symptoms
but without resolution of symptoms
but without resolution of symptoms
but without resolution of symptoms
but without resolution of symptoms
in 2009  hypertension  new onset type 2 diabetes  and hypercholesterolemia who presents with the sudden onset of substernal chest pain status post exercise
in 2005  3vessel percutaneous transluminal coronary angioplasty in 2009  hypertension  new onset type 2 diabetes  and hypercholesterolemia who presents with the sudden onset of substernal chest pain status post exercise







times two  who presented with acute coronary syndrome refractory to medical treatment and TNK  now status post AngioJet percutaneous transluminal coronary angioplasty and stent of proximal left anterior descending artery and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement
and TNK  now status post AngioJet percutaneous transluminal coronary angioplasty and stent of proximal left anterior descending artery and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement

times two  who presented with acute coronary syndrome refractory to medical treatment and TNK  now status post AngioJet percutaneous transluminal coronary angioplasty and stent of proximal left anterior descending artery and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement
and stent of proximal left anterior descending artery and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement
now status post AngioJet percutaneous transluminal coronary angioplasty and stent of proximal left anterior descending artery and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement
and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement
times two  who presented with acute coronary syndrome refractory to medical treatment and TNK  now status post AngioJet percutaneous transluminal coronary angioplasty and stent of proximal left anterior descending artery and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement
and TNK  now status post AngioJet percutaneous transluminal coronary angioplasty and stent of proximal left anterior descending artery and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement

times two  who presented with acute coronary syndrome refractory to medical treatment and TNK  now status post AngioJet percutaneous transluminal coronary angioplasty and stent of proximal left anterior descending artery and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement
and stent of proximal left anterior descending artery and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement
now status post AngioJet percutaneous transluminal coronary angioplasty and stent of proximal left anterior descending artery and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement
and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement
status post exercise
status post exercise
times two  who presented with acute coronary syndrome refractory to medical treatment and TNK  now status post AngioJet percutaneous transluminal coronary angioplasty and stent of proximal left anterior descending artery and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement
and TNK  now status post AngioJet percutaneous transluminal coronary angioplasty and stent of proximal left anterior descending artery and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement

times two  who presented with acute coronary syndrome refractory to medical treatment and TNK  now status post AngioJet percutaneous transluminal coronary angioplasty and stent of proximal left anterior descending artery and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement
and stent of proximal left anterior descending artery and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement
now status post AngioJet percutaneous transluminal coronary angioplasty and stent of proximal left anterior descending artery and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement
and percutaneous transluminal coronary angioplasty of first diagonal with intraaortic balloon pump placement
new onset type 2 diabetes  and hypercholesterolemia who presents with the sudden onset of substernal chest pain status post exercise
new onset type 2 diabetes  and hypercholesterolemia who presents with the sudden onset of substernal chest pain status post exercise

and IODINE
who presents with the sudden onset of substernal chest pain status post exercise
who presents with the sudden onset of substernal chest pain status post exercise
and hypercholesterolemia who presents with the sudden onset of substernal chest pain status post exercise
and hypercholesterolemia who presents with the sudden onset of substernal chest pain status post exercise





on top of a preexisting alkalosis

of over 36 L during his admission
given for agitation on top of a preexisting alkalosis



33 years ago
was placed
based on UA positive for WBC
but resolved after continued diuresis

Lasix 80 mg IV  and Combivent neb
80 mg IV  and Combivent neb

are among the most common causes
and infection are among the most common causes
and MS changes

at 70
with normal saline or commercial wound cleaner  thin layer of Duoderm gel  air dry  allevyn foam adhesive over the site  and change every 2 days or prn
or commercial wound cleaner  thin layer of Duoderm gel  air dry  allevyn foam adhesive over the site  and change every 2 days or prn
thin layer of Duoderm gel  air dry  allevyn foam adhesive over the site  and change every 2 days or prn
air dry  allevyn foam adhesive over the site  and change every 2 days or prn
over the site  and change every 2 days or prn
was held
pat dry  pack aquacel AG rope and moisten with saline  cover with dry gauze and change daily
cover with dry gauze and change daily
and moisten with saline  cover with dry gauze and change daily
and change daily



removed from right pleural space

on 20170906  1600 mL of serosanguinous fluid removed from right pleural space
given for agitation on top of a preexisting alkalosis
and this was continued this entire admission
33 yrs ago  COPD  T2DM  and AICD pocket infection who presented to the Juan on 20170903 with worsening SOB x 5 days and feeling  cloudy
T2DM  and AICD pocket infection who presented to the Juan on 20170903 with worsening SOB x 5 days and feeling  cloudy
and AICD pocket infection who presented to the Juan on 20170903 with worsening SOB x 5 days and feeling  cloudy
x 5 days and feeling  cloudy
who presented to the Juan on 20170903 with worsening SOB x 5 days and feeling  cloudy
sp mediastinal exploration  evacuation of pericardial effusion  hematoma  20170724
20170724
of pericardial effusion  hematoma  20170724
of pericardial effusion  hematoma  20170724
of pericardial effusion  hematoma  20170724
and Cdifficile colitis treated with Vancomycin and Flagyl with a course of Levophed
and Flagyl with a course of Levophed
with a course of Levophed

0809
0808  and Vancomycin  0809
0809
0808  and Vancomycin  0809
0222 failure to wean  sepsis and Cdifficile colitis treated with Vancomycin and Flagyl with a course of Levophed
and Flagyl with a course of Levophed
with a course of Levophed

0222 failure to wean  sepsis and Cdifficile colitis treated with Vancomycin and Flagyl with a course of Levophed
and Flagyl with a course of Levophed
with a course of Levophed

sepsis and Cdifficile colitis treated with Vancomycin and Flagyl with a course of Levophed
and Flagyl with a course of Levophed
with a course of Levophed

and chemotherapy in French Guiana  sp right pneumonectomy in 20160921 for recurrence
in French Guiana  sp right pneumonectomy in 20160921 for recurrence
in 20160921 for recurrence



in 20160921 for recurrence
in Western Sahara  sp right pneumonectomy in 20160921 for recurrence
and chemotherapy in Western Sahara  sp right pneumonectomy in 20160921 for recurrence




treated with Vancomycin and Flagyl with a course of Levophed
and Flagyl with a course of Levophed
with a course of Levophed

155500035 on 0808
205 and back on AC 155500035 on 0808
rate 74
500 mg PO X 1 dose






20170721 0222 failure to wean
completed 0810
completed 0810
rate 83 bpm
0222 failure to wean  sepsis and Cdifficile colitis treated with Vancomycin and Flagyl with a course of Levophed
and Flagyl with a course of Levophed
with a course of Levophed

20170721  treated with Vancomycin

and sepsis 20170721  treated with Vancomycin




with improvement in BP
treated with Flagyl  completed 0810
completed 0810
in 20181110 Dumas was complicated by a PEA arrest secondary to PE



1114

ho PE  sp PEA arrest 1114

secondary to PE
A arrest secondary to PE

ie Linezolid  initially
initially
was started for presumed VRE infection in the urine
Pt has ESRD secondary to her DM and is on HD
Pt has ESRD secondary to her DM and is on HD
to be treated with fluconazole for total 7 days
for yeast in the urine  to be treated with fluconazole for total 7 days

while septic and then transitioned back to insulin sliding scale
was started for presumed VRE infection in the urine

and then transitioned back to insulin sliding scale

however this was stopped when C Diff B toxin came back negative on 20190110



hypercholestrolemia anemia of chornic disease ho PE  sp PEA arrest 1114
type 2 diabetes hypercholestrolemia anemia of chornic disease ho PE  sp PEA arrest 1114
for airway protection



1114

1114


1114


and vancomycin

and is on HD
Pt has ESRD secondary to her DM and is on HD
on HD  Pt has ESRD secondary to her DM and is on HD
Pt has ESRD secondary to her DM and is on HD


type 2 DM  and recent PE resulting in PEA arrest admitted through the Juan with sepsis of unknown etiology
type 2 DM  and recent PE resulting in PEA arrest admitted through the Juan with sepsis of unknown etiology
admitted through the Juan with sepsis of unknown etiology
type 2 DM  and recent PE resulting in PEA arrest admitted through the Juan with sepsis of unknown etiology
admitted through the Juan with sepsis of unknown etiology
admitted through the Juan with sepsis of unknown etiology
of unknown etiology
of unknown etiology

of unknown etiology
type 2 DM  and recent PE resulting in PEA arrest admitted through the Juan with sepsis of unknown etiology
and recent PE resulting in PEA arrest admitted through the Juan with sepsis of unknown etiology
type 2 DM  and recent PE resulting in PEA arrest admitted through the Juan with sepsis of unknown etiology
and recent PE resulting in PEA arrest admitted through the Juan with sepsis of unknown etiology
and recent PE resulting in PEA arrest admitted through the Juan with sepsis of unknown etiology
resulting in PEA arrest admitted through the Juan with sepsis of unknown etiology
type 2 DM  and recent PE resulting in PEA arrest admitted through the Juan with sepsis of unknown etiology
resulting in PEA arrest admitted through the Juan with sepsis of unknown etiology
resulting in PEA arrest admitted through the Juan with sepsis of unknown etiology
on HD  type 2 DM  and recent PE resulting in PEA arrest admitted through the Juan with sepsis of unknown etiology
type 2 DM  and recent PE resulting in PEA arrest admitted through the Juan with sepsis of unknown etiology
significant for ESRD on HD  type 2 DM  and recent PE resulting in PEA arrest admitted through the Juan with sepsis of unknown etiology
type 2 DM  and recent PE resulting in PEA arrest admitted through the Juan with sepsis of unknown etiology

sp PEA arrest 1114
anemia of chornic disease ho PE  sp PEA arrest 1114
pulmonary hypertension and mitral regurgitation  and atrial fibrillation
and mitral regurgitation  and atrial fibrillation
with an ejection fraction of 45 and a recent cardiac myocardial infarction  pulmonary hypertension and mitral regurgitation  and atrial fibrillation

for his prostate cancer
for his prostate cancer
in the low 100s
and atrial fibrillation

had been weaned off prior to his admission
status post brachytherapy  history of rectal bleeding  obstructive sleep apnea on CPAP
history of rectal bleeding  obstructive sleep apnea on CPAP

and atrial flutter  history of prostate cancer  status post brachytherapy  history of rectal bleeding  obstructive sleep apnea on CPAP
history of rectal bleeding  obstructive sleep apnea on CPAP

history of prostate cancer  status post brachytherapy  history of rectal bleeding  obstructive sleep apnea on CPAP
history of rectal bleeding  obstructive sleep apnea on CPAP

pulmonary hypertension  history of atrial fibrillation and atrial flutter  history of prostate cancer  status post brachytherapy  history of rectal bleeding  obstructive sleep apnea on CPAP
history of rectal bleeding  obstructive sleep apnea on CPAP


reported by the patient during a barium swallow 25 years ago
to barium reported by the patient during a barium swallow 25 years ago
25 years ago
and it is recommended that he follow up with his gastroenterologist for repeat Argon laser therapy

obstructive sleep apnea on CPAP
obstructive sleep apnea on CPAP

and short of breath
rightsided congestive heart failure  pulmonary hypertension  history of atrial fibrillation and atrial flutter  history of prostate cancer  status post brachytherapy  history of rectal bleeding  obstructive sleep apnea on CPAP
history of rectal bleeding  obstructive sleep apnea on CPAP

history of atrial fibrillation and atrial flutter  history of prostate cancer  status post brachytherapy  history of rectal bleeding  obstructive sleep apnea on CPAP
history of rectal bleeding  obstructive sleep apnea on CPAP

on CPAP
on CPAP




s
s
Pleural disorder
sp Lap cholectomy  sp Total abdominal hysterectomy


sp Total abdominal hysterectomy
sp Total abdominal hysterectomy
sp Lap cholectomy  sp Total abdominal hysterectomy
Pleural disorder



Pleural disorder
Chronic renal insufficiency  sp Appendectomy  sp Lap cholectomy  sp Total abdominal hysterectomy
Chronic renal insufficiency  sp Appendectomy  sp Lap cholectomy  sp Total abdominal hysterectomy

Chronic renal insufficiency  sp Appendectomy  sp Lap cholectomy  sp Total abdominal hysterectomy
sp Total abdominal hysterectomy
sp Lap cholectomy  sp Total abdominal hysterectomy
B12 deficiency  Chronic renal insufficiency  sp Appendectomy  sp Lap cholectomy  sp Total abdominal hysterectomy
B12 deficiency  Chronic renal insufficiency  sp Appendectomy  sp Lap cholectomy  sp Total abdominal hysterectomy

B12 deficiency  Chronic renal insufficiency  sp Appendectomy  sp Lap cholectomy  sp Total abdominal hysterectomy
sp Total abdominal hysterectomy
sp Lap cholectomy  sp Total abdominal hysterectomy
Gastritis  B12 deficiency  Chronic renal insufficiency  sp Appendectomy  sp Lap cholectomy  sp Total abdominal hysterectomy
Gastritis  B12 deficiency  Chronic renal insufficiency  sp Appendectomy  sp Lap cholectomy  sp Total abdominal hysterectomy

Gastritis  B12 deficiency  Chronic renal insufficiency  sp Appendectomy  sp Lap cholectomy  sp Total abdominal hysterectomy
sp Total abdominal hysterectomy
sp Lap cholectomy  sp Total abdominal hysterectomy
by vascular surgery on 1030
x 2
Pleural disorder


sp Appendectomy  sp Lap cholectomy  sp Total abdominal hysterectomy
sp Appendectomy  sp Lap cholectomy  sp Total abdominal hysterectomy

sp Appendectomy  sp Lap cholectomy  sp Total abdominal hysterectomy
sp Total abdominal hysterectomy
sp Lap cholectomy  sp Total abdominal hysterectomy
Pleural disorder
Pleural disorder
sp Lap cholectomy  sp Total abdominal hysterectomy


sp Total abdominal hysterectomy
sp Total abdominal hysterectomy
sp Lap cholectomy  sp Total abdominal hysterectomy
sp Lap cholectomy  sp Total abdominal hysterectomy


sp Total abdominal hysterectomy
sp Total abdominal hysterectomy
sp Lap cholectomy  sp Total abdominal hysterectomy
sp Lap cholectomy  sp Total abdominal hysterectomy


sp Total abdominal hysterectomy
sp Total abdominal hysterectomy
sp Lap cholectomy  sp Total abdominal hysterectomy

who was admitted for COPD exacerbation and worsening of upper respiratory tract infection symptoms for a week prior to admission
who was admitted for COPD exacerbation and worsening of upper respiratory tract infection symptoms for a week prior to admission
or communityacquired pneumonia

exacerbation but he appeared in more respiratory distress overnight and was started on IV SoluMedrol and more frequent nebulizers for COPD
exacerbation but he appeared in more respiratory distress overnight and was started on IV SoluMedrol and more frequent nebulizers for COPD
exacerbation but he appeared in more respiratory distress overnight and was started on IV SoluMedrol and more frequent nebulizers for COPD
six years ago but not on home 02 with recent FEV1 27 of predicted value  and FEV1FVC ratio 56 of hypercholesterolemia  who was admitted for COPD exacerbation and worsening of upper respiratory tract infection symptoms for a week prior to admission
with recent FEV1 27 of predicted value  and FEV1FVC ratio 56 of hypercholesterolemia  who was admitted for COPD exacerbation and worsening of upper respiratory tract infection symptoms for a week prior to admission
and worsening of upper respiratory tract infection symptoms for a week prior to admission
and worsening of upper respiratory tract infection symptoms for a week prior to admission

prednisone and frequent nebulizers for COPD
but he appeared in more respiratory distress overnight and was started on IV SoluMedrol and more frequent nebulizers for COPD
but he appeared in more respiratory distress overnight and was started on IV SoluMedrol and more frequent nebulizers for COPD   steroids and to CMED for management of COPD exacerbation but he appeared in more respiratory distress overnight and was started on IV SoluMedrol and more frequent nebulizers for COPD
for COPD
and more frequent nebulizers for COPD
overnight and was started on IV SoluMedrol and more frequent nebulizers for COPD
for COPD
and more frequent nebulizers for COPD

for a week prior to admission
for a week prior to admission


and ascites

following the procedure

and the patient was transferred to the intensive care unit while still intubated following the procedure
and now has good graft function





for swelling reduction


for 3 more days
found in your lungs









were removed


was placed for decompression


and left knee injury

was not required

and IV fluids



history of intubation



500 mg daily and ceftriaxone

of Zithromax 500 mg daily and ceftriaxone
500 mg daily and ceftriaxone

of Zithromax 500 mg daily and ceftriaxone


responding to 3 fluid boluses over the course of the night
over the course of the night
down to 7528 and bradycardiac  responding to 3 fluid boluses over the course of the night
over the course of the night
and obstructing

and known gastritis

history of intubation
at home
at home
at home
at home
however  she was hemodynamically stable that morning and was transferred back out to the floor


of her shortness of breath

and was started on replacement
at St Margarets Center for Women  Infants in 032006




hypoxemia  and bibasilar pneumonia













most recently on Sutent monotherapy since 20181221  with mild renal insufficiency  who presented from home on 20190614 with shortness of breath and fever
and sorafenib  most recently on Sutent monotherapy since 20181221  with mild renal insufficiency  who presented from home on 20190614 with shortness of breath and fever
since 20181221  with mild renal insufficiency  who presented from home on 20190614 with shortness of breath and fever
in 20180321  status post Avastin and sorafenib  most recently on Sutent monotherapy since 20181221  with mild renal insufficiency  who presented from home on 20190614 with shortness of breath and fever
and fever
and fever
and fever
and fever
and bibasilar pneumonia

since 20181221  admitted with fever  hypoxemia  and bibasilar pneumonia

was held on admission in light of acute infection
who presented from home on 20190614 with shortness of breath and fever
who presented from home on 20190614 with shortness of breath and fever
who presented from home on 20190614 with shortness of breath and fever
who presented from home on 20190614 with shortness of breath and fever

and internal fixation

and internal fixation
or purulence noted
noted
intact and no erythema or purulence noted
as needed

once per day
with dry gauze once per day



on 20120306
called hyperCVAD on 20120306
on 20120306
called hyperCVAD on 20120306
were discontinued



and Intensive Care Unit stay in addition to polypharmacy

in 2003 secondary to diabetic nephropathy  as well as throat cancer in 2004 treated with local resection and radical neck dissection on the left as well as postoperative radiation

and radical neck dissection on the left as well as postoperative radiation
as well as postoperative radiation
as well as throat cancer in 2004 treated with local resection and radical neck dissection on the left as well as postoperative radiation

and radical neck dissection on the left as well as postoperative radiation
as well as postoperative radiation
performed 20100827
and they were replaced early on 0831






and BiPAP machine  although continued to saturate well
although continued to saturate well
were discontinued  those included Temocillin  Nortriptyline  Haldol  Lorazepam  Venlafaxine  Bupropion  and Gabapentin
Nortriptyline  Haldol  Lorazepam  Venlafaxine  Bupropion  and Gabapentin
Haldol  Lorazepam  Venlafaxine  Bupropion  and Gabapentin
Venlafaxine  Bupropion  and Gabapentin
Lorazepam  Venlafaxine  Bupropion  and Gabapentin
Bupropion  and Gabapentin
and Gabapentin

self catheterization

once his delirium had resolved
had resolved   Tylenol once his delirium had resolved
in 2004 treated with local resection and radical neck dissection on the left as well as postoperative radiation

and radical neck dissection on the left as well as postoperative radiation
as well as postoperative radiation

in 2004
and XRT in 2004
in 2003
in 2003
and he also received packed red blood cells

and he also received packed red blood cells



and


as an inpatient
his coronary artery disease and his significantly dilated ascending aortic aneurysm

and his significantly dilated ascending aortic aneurysm



because of his stroke



and basal insulin to maintain his blood sugars at a more appropriate level
to maintain his blood sugars at a more appropriate level



was discontinued
was discontinued


for ten days after discharge to treat the E coli in his urine
and continue Bactrim for ten days after discharge to treat the E coli in his urine

is clean  dry and intact at the end of the procedure
and he has hypercholesterolemia  for which he receives nothing at this time

and his sternal wound is clean  dry and intact at the end of the procedure
for which he receives nothing at this time
pink  with stool





and friable colonic tissue






in place  allow them to fall off on their own

small bowel repair

small bowel repair
removed on POD 2718
so TPN was reinitiated
was reinitiated
to nonoperative treatment
to nonoperative treatment
to nonoperative treatment


while in ICU
while in ICU







pink  with stool

of a leak from Relaford pouch and repair of colovesicular fistula
and repair of colovesicular fistula
and repair of colovesicular fistula

now doing well
now doing well
now doing well
now doing well
now doing well

with question of L retrocardiac infiltrate  now doing well
for airway protection  with question of L retrocardiac infiltrate  now doing well
Klonopin  Geodon  sT Jackson stay with intubation for airway protection  with question of L retrocardiac infiltrate  now doing well
sT Jackson stay with intubation for airway protection  with question of L retrocardiac infiltrate  now doing well
Geodon  sT Jackson stay with intubation for airway protection  with question of L retrocardiac infiltrate  now doing well
with question of L retrocardiac infiltrate  now doing well
for airway protection  with question of L retrocardiac infiltrate  now doing well
Klonopin  Geodon  sT Jackson stay with intubation for airway protection  with question of L retrocardiac infiltrate  now doing well
sT Jackson stay with intubation for airway protection  with question of L retrocardiac infiltrate  now doing well
Geodon  sT Jackson stay with intubation for airway protection  with question of L retrocardiac infiltrate  now doing well
with question of L retrocardiac infiltrate  now doing well
for airway protection  with question of L retrocardiac infiltrate  now doing well
Klonopin  Geodon  sT Jackson stay with intubation for airway protection  with question of L retrocardiac infiltrate  now doing well
sT Jackson stay with intubation for airway protection  with question of L retrocardiac infiltrate  now doing well
Geodon  sT Jackson stay with intubation for airway protection  with question of L retrocardiac infiltrate  now doing well
open to air  clean and dry
with a 21 mosaic porcine valve








for 30 doses
for 30 doses



or pain

in 903

with serosal implants in 903
for 14 days
x4 in  03
x4 in  03
sp CABG x4 in  03
x4 in  03
0907
0907
0907
0907
it  but pt did not tolerate the procedure and asked that it be deferred
and asked that it be deferred
in blood cx from Fri  Followup cx has been NGTD


or tenderness
but was then transferred back to the floor in stable condition
but was then transferred back to the floor in stable condition
0207 fluid accumulation
but never healed
but never healed

was sensitive but Klebsiella unknown
unknown
and albumin  these were
octreotide and albumin  these were
these were

and + Klebsiella
and anemia
albumin for hepatorenal
for hepatorenal
midodrine  albumin for hepatorenal
confusion and anemia
+ Enterococcus and + Klebsiella

and UTI + Enterococcus and + Klebsiella
which improved temp to 967
and relieved her abdominal pain


and there was concern for bleed into her abdomen
and there was concern for bleed into her abdomen


6 liters  followed by replacement with albumin
despite replacement with albumin

despite replacement with albumin

though she had no other evidence of sepsis
though she had no other evidence of sepsis
reversed flow in main portal vein  presents from liver clinic with increasing abdominal girth
reversed flow in main portal vein  presents from liver clinic with increasing abdominal girth
reversed flow in main portal vein  presents from liver clinic with increasing abdominal girth
reversed flow in main portal vein  presents from liver clinic with increasing abdominal girth



that ruled out SBP and relieved her abdominal pain
candidate  the

once they
and CT scan revealing fluid and gas in the endometrial cavity






vs hysterectomy

to 1023
and admission

and admission

x 1
until hospital day number five  when she had a temperature spike to 1023
on 20090107

and clindamycin

with continued abdominal pain and CT scan revealing fluid and gas in the endometrial cavity


GIVEN  ON TOP OF WOUND
OR CLEAN WATER THREE TIMES A DAY AND PLACE ANTIBIOTIC OINTMENT  GIVEN  ON TOP OF WOUND



of the hip and right wrist fracture ORIF  who was in the hospital for this event  when it was noted that she had abdominal pain  distention and coffee ground emesis with worsening mental status and renal failure
ORIF  who was in the hospital for this event  when it was noted that she had abdominal pain  distention and coffee ground emesis with worsening mental status and renal failure
causing beam hardening artifact



and peritonitis with gross soilage with bile and gastric contents
of intraabdominal abscess and peritonitis with gross soilage with bile and gastric contents

of intraabdominal abscess and peritonitis with gross soilage with bile and gastric contents
with gross soilage with bile and gastric contents
of intraabdominal abscess and peritonitis with gross soilage with bile and gastric contents
with internal and external drainage

of perforated posterior duodenal ulcer with internal and external drainage

with internal and external drainage
and wide drainage of perforated posterior duodenal ulcer with internal and external drainage

and renal failure
and renal failure
distention and coffee ground emesis with worsening mental status and renal failure
distention and coffee ground emesis with worsening mental status and renal failure


and coffee ground emesis with worsening mental status and renal failure
and coffee ground emesis with worsening mental status and renal failure



ISS


with internal and external drainage
with internal and external drainage
with internal and external drainage

with internal and external drainage
with internal and external drainage
to hold the bp
on pressors to hold the bp
in 052001
in 052001
and peritonitis with gross soilage with bile and gastric contents
and peritonitis with gross soilage with bile and gastric contents
with gross soilage with bile and gastric contents
with gross soilage with bile and gastric contents



and normal flow  see PTCA comments
and normal flow  see PTCA comments
and normal flow  see PTCA comments
and stenting of the proximal LAD with overlapping 225 x 13 mm and 225 x 18 mm Hepacoat stents with no residual stenosis or dissection and normal flow  see PTCA comments
or dissection and normal flow  see PTCA comments
or dissection and normal flow  see PTCA comments
or dissection and normal flow  see PTCA comments
and stenting of the proximal LAD with overlapping 225 x 13 mm and 225 x 18 mm Hepacoat stents with no residual stenosis or dissection and normal flow  see PTCA comments
with worsening mental status and renal failure
with worsening mental status and renal failure


causing beam hardening artifact

of the hip and right wrist fracture ORIF  who was in the hospital for this event  when it was noted that she had abdominal pain  distention and coffee ground emesis with worsening mental status and renal failure
and right wrist fracture ORIF  who was in the hospital for this event  when it was noted that she had abdominal pain  distention and coffee ground emesis with worsening mental status and renal failure
was performed four days ago

in place
in place
and tongue injury


but awake
in her intravenous fluids

shivering  but awake



secondary to cholecystectomy performed four days prior to admission
performed four days prior to admission
administration and was transferred to the CMED CCU for close observation
administration and was transferred to the CMED CCU for close observation
administration and was transferred to the CMED CCU for close observation



and Droperidol
morphine sulfate and Droperidol

for stricture
from outside hospital blood cultures







and this is day  14 of antibiotics
likely dt inability to take meds in setting of NV




as inpatient and taking NPH 2 units BID at home
2 units BID at home
without difficulty on 0124
well  and underwent dialysis without difficulty on 0124

ordered to rule out abscess at the site
ordered to rule out abscess at the site


without difficulty
without difficulty on 0124
well  and underwent dialysis without difficulty on 0124
without difficulty on 0124
well  and underwent dialysis without difficulty on 0124
on 0124
on 0124


since it was placed
pt was tolerating PO meds  diet at time of admission to medical service and was restarted on oral reglan
diet at time of admission to medical service and was restarted on oral reglan

reglan  pt was tolerating PO meds  diet at time of admission to medical service and was restarted on oral reglan
dilaudid  reglan  pt was tolerating PO meds  diet at time of admission to medical service and was restarted on oral reglan
last in 1226 per patient  who presents to CMED CCU with hypertensive urgency unable from the Larry
last in 1226 per patient  who presents to CMED CCU with hypertensive urgency unable from the Larry
last in 1226 per patient  who presents to CMED CCU with hypertensive urgency unable from the Larry
pt was tolerating PO meds  diet at time of admission to medical service and was restarted on oral reglan
diet at time of admission to medical service and was restarted on oral reglan

reglan  pt was tolerating PO meds  diet at time of admission to medical service and was restarted on oral reglan
dilaudid  reglan  pt was tolerating PO meds  diet at time of admission to medical service and was restarted on oral reglan

in setting of NV
pt was tolerating PO meds  diet at time of admission to medical service and was restarted on oral reglan
diet at time of admission to medical service and was restarted on oral reglan

reglan  pt was tolerating PO meds  diet at time of admission to medical service and was restarted on oral reglan
dilaudid  reglan  pt was tolerating PO meds  diet at time of admission to medical service and was restarted on oral reglan
pt was tolerating PO meds  diet at time of admission to medical service and was restarted on oral reglan
diet at time of admission to medical service and was restarted on oral reglan

reglan  pt was tolerating PO meds  diet at time of admission to medical service and was restarted on oral reglan
dilaudid  reglan  pt was tolerating PO meds  diet at time of admission to medical service and was restarted on oral reglan
x2  March and 20180707
in AV fistula
pt with ho numerous clots in AV fistula

that evening
so he stayed in the ICU for closer monitoring of respiratory status  which spontaneously improved
was started

last in 1226 per patient  who presents to CMED CCU with hypertensive urgency unable from the Larry
unable from the Larry
unable from the Larry
started 20170107 on Tu  Th  Sat





were not visualized

for 4 days
and later with PO medication








at this time


vanc  levo  then 2 week course of Linazolid with resolution of fevers and decreased pulmonary secretions
with resolution of fevers and decreased pulmonary secretions
then 2 week course of Linazolid with resolution of fevers and decreased pulmonary secretions
levo  then 2 week course of Linazolid with resolution of fevers and decreased pulmonary secretions
vanc  levo  then 2 week course of Linazolid with resolution of fevers and decreased pulmonary secretions
with resolution of fevers and decreased pulmonary secretions
then 2 week course of Linazolid with resolution of fevers and decreased pulmonary secretions
levo  then 2 week course of Linazolid with resolution of fevers and decreased pulmonary secretions




and decreased pulmonary secretions
and decreased pulmonary secretions
and decreased pulmonary secretions
and decreased pulmonary secretions


on 20141027
on 20141027


and nasogastric tube placement

is present  and the patient is intubated













with six proximal and two distal screws

and Sulfa
at the end of his first unit of packed cells  he did subsequently receive the remaining 2 units without any further reaction
he did subsequently receive the remaining 2 units without any further reaction
without any further reaction

serial head CT scans were performed and were stable

with an intramedullary rod and side plate






or school age siblings with chronic lung disease
or school age siblings with chronic lung disease
and bradycardia of prematurity
and weight abnormalities or school age siblings with chronic lung disease
and weight abnormalities or school age siblings with chronic lung disease






is recommended for household contacts and out of home care givers

and treatment of CHF
of CHF
and treatment of CHF
of CHF
and it was recommended to treat CHF
vs atelectasis  levoflox started 0524 and subsequently stopped  no consolidations on CXR and afebrile
were transudative  secondary to CHF  and it was recommended to treat CHF
secondary to CHF  and it was recommended to treat CHF
and it was recommended to treat CHF
complicated by PTX requiring chest tube which resolved and tube was removed during admit for pacer  no evidence of PTX on most recent CXR
placed 0508 in DDDR mode  complicated by PTX requiring chest tube which resolved and tube was removed during admit for pacer  no evidence of PTX on most recent CXR
which resolved and tube was removed during admit for pacer  no evidence of PTX on most recent CXR
placed 0508 in DDDR mode  complicated by PTX requiring chest tube which resolved and tube was removed during admit for pacer  no evidence of PTX on most recent CXR
which resolved and tube was removed during admit for pacer  no evidence of PTX on most recent CXR
pacer placed 0508 in DDDR mode  complicated by PTX requiring chest tube which resolved and tube was removed during admit for pacer  no evidence of PTX on most recent CXR
requiring chest tube which resolved and tube was removed during admit for pacer  no evidence of PTX on most recent CXR
requiring chest tube which resolved and tube was removed during admit for pacer  no evidence of PTX on most recent CXR
which resolved and tube was removed during admit for pacer  no evidence of PTX on most recent CXR
placed 0508 in DDDR mode  complicated by PTX requiring chest tube which resolved and tube was removed during admit for pacer  no evidence of PTX on most recent CXR
which resolved and tube was removed during admit for pacer  no evidence of PTX on most recent CXR
requiring chest tube which resolved and tube was removed during admit for pacer  no evidence of PTX on most recent CXR
given lasix x 1 bolus 100 mg  responded somewhat and o2 sat stable in low 90 s
put on face mask  given lasix x 1 bolus 100 mg  responded somewhat and o2 sat stable in low 90 s
x 1 bolus 100 mg  responded somewhat and o2 sat stable in low 90 s
zosyn  put on face mask  given lasix x 1 bolus 100 mg  responded somewhat and o2 sat stable in low 90 s
started 0524 and subsequently stopped  no consolidations on CXR and afebrile
started 0524 and subsequently stopped  no consolidations on CXR and afebrile

and boluses
with IV lasix gtt and boluses


started 0524 and subsequently stopped  no consolidations on CXR and afebrile
with echo showing no evidence of tamponade  who is transferred for possible pericardial effusion drainage and treatment of CHF  as well as drainage of bilateral pleural effusions
with echo showing no evidence of tamponade  who is transferred for possible pericardial effusion drainage and treatment of CHF  as well as drainage of bilateral pleural effusions
with echo showing no evidence of tamponade  who is transferred for possible pericardial effusion drainage and treatment of CHF  as well as drainage of bilateral pleural effusions
with echo showing no evidence of tamponade  who is transferred for possible pericardial effusion drainage and treatment of CHF  as well as drainage of bilateral pleural effusions
with echo showing no evidence of tamponade  who is transferred for possible pericardial effusion drainage and treatment of CHF  as well as drainage of bilateral pleural effusions
on 0508 for symptomatic pauses is transferred for large pericardial effusion
although this was not seen on imaging
although this was not seen on imaging
control  revert back to a fib on 0529  which was stopped when the pt was made CMO
control  revert back to a fib on 0529  which was stopped when the pt was made CMO

by exam
located in RV apex
located in RV apex
located in RV apex
etiology most likely 0215 CHF

which had been dc d in the hospital after resolution of her PTX
requiring CT placement which had been dc d in the hospital after resolution of her PTX
located in RV apex
diagnostic and therapeutic  with studies consistent with transudate  etiology most likely 0215 CHF

or repeat thoracenteses

on 0508 for symptomatic pauses is transferred for large pericardial effusion
on 0508 for symptomatic pauses is transferred for large pericardial effusion
by echo performed at bedside by cards fellow
on 0508 for symptomatic pauses is transferred for large pericardial effusion
on 0508 for symptomatic pauses is transferred for large pericardial effusion

increased to NRB  wherein she was satting upper 80 s low 90 s
wherein she was satting upper 80 s low 90 s

located in RV apex
located in RV apex
is transferred for large pericardial effusion

and CHF



however she had a normal echo appearance of lead  no tamponade by exam
however she had a normal echo appearance of lead  no tamponade by exam
and treatment of CHF  as well as drainage of bilateral pleural effusions
and treatment of CHF  as well as drainage of bilateral pleural effusions
of CHF  as well as drainage of bilateral pleural effusions
0508 cb PTX requiring CT  CAD  who was readmitted 0524 with ARF and lethargy  found to have a large pericardial effusion and bilateral pleural effusions  with echo showing no evidence of tamponade  who is transferred for possible pericardial effusion drainage and treatment of CHF  as well as drainage of bilateral pleural effusions
CAD  who was readmitted 0524 with ARF and lethargy  found to have a large pericardial effusion and bilateral pleural effusions  with echo showing no evidence of tamponade  who is transferred for possible pericardial effusion drainage and treatment of CHF  as well as drainage of bilateral pleural effusions




more so than UA at OSH  so felt possibly levoresistant
more so than UA at OSH  so felt possibly levoresistant

which had been discontinued about 1 week ago


and treatment of CHF  as well as drainage of bilateral pleural effusions
and treatment of CHF  as well as drainage of bilateral pleural effusions
of CHF  as well as drainage of bilateral pleural effusions
0508 cb PTX requiring CT  CAD  who was readmitted 0524 with ARF and lethargy  found to have a large pericardial effusion and bilateral pleural effusions  with echo showing no evidence of tamponade  who is transferred for possible pericardial effusion drainage and treatment of CHF  as well as drainage of bilateral pleural effusions
CAD  who was readmitted 0524 with ARF and lethargy  found to have a large pericardial effusion and bilateral pleural effusions  with echo showing no evidence of tamponade  who is transferred for possible pericardial effusion drainage and treatment of CHF  as well as drainage of bilateral pleural effusions


and treatment of CHF  as well as drainage of bilateral pleural effusions
and treatment of CHF  as well as drainage of bilateral pleural effusions
of CHF  as well as drainage of bilateral pleural effusions
who was readmitted 0524 with ARF and lethargy  found to have a large pericardial effusion and bilateral pleural effusions  with echo showing no evidence of tamponade  who is transferred for possible pericardial effusion drainage and treatment of CHF  as well as drainage of bilateral pleural effusions
who was readmitted 0524 with ARF and lethargy  found to have a large pericardial effusion and bilateral pleural effusions  with echo showing no evidence of tamponade  who is transferred for possible pericardial effusion drainage and treatment of CHF  as well as drainage of bilateral pleural effusions

on 0508 for symptomatic pauses is transferred for large pericardial effusion
and treatment of CHF  as well as drainage of bilateral pleural effusions
and treatment of CHF  as well as drainage of bilateral pleural effusions
of CHF  as well as drainage of bilateral pleural effusions
with echo showing no evidence of tamponade  who is transferred for possible pericardial effusion drainage and treatment of CHF  as well as drainage of bilateral pleural effusions
with echo showing no evidence of tamponade  who is transferred for possible pericardial effusion drainage and treatment of CHF  as well as drainage of bilateral pleural effusions
with symptomatic bradycardia  cb R PTX requiring chest tube

cb R PTX requiring chest tube

and treatment of CHF  as well as drainage of bilateral pleural effusions
and treatment of CHF  as well as drainage of bilateral pleural effusions
of CHF  as well as drainage of bilateral pleural effusions
and bilateral pleural effusions  with echo showing no evidence of tamponade  who is transferred for possible pericardial effusion drainage and treatment of CHF  as well as drainage of bilateral pleural effusions
and bilateral pleural effusions  with echo showing no evidence of tamponade  who is transferred for possible pericardial effusion drainage and treatment of CHF  as well as drainage of bilateral pleural effusions
and treatment of CHF  as well as drainage of bilateral pleural effusions
and treatment of CHF  as well as drainage of bilateral pleural effusions
of CHF  as well as drainage of bilateral pleural effusions
and lethargy  found to have a large pericardial effusion and bilateral pleural effusions  with echo showing no evidence of tamponade  who is transferred for possible pericardial effusion drainage and treatment of CHF  as well as drainage of bilateral pleural effusions
and lethargy  found to have a large pericardial effusion and bilateral pleural effusions  with echo showing no evidence of tamponade  who is transferred for possible pericardial effusion drainage and treatment of CHF  as well as drainage of bilateral pleural effusions
and treatment of CHF  as well as drainage of bilateral pleural effusions
and treatment of CHF  as well as drainage of bilateral pleural effusions
of CHF  as well as drainage of bilateral pleural effusions
found to have a large pericardial effusion and bilateral pleural effusions  with echo showing no evidence of tamponade  who is transferred for possible pericardial effusion drainage and treatment of CHF  as well as drainage of bilateral pleural effusions
found to have a large pericardial effusion and bilateral pleural effusions  with echo showing no evidence of tamponade  who is transferred for possible pericardial effusion drainage and treatment of CHF  as well as drainage of bilateral pleural effusions
and treatment of CHF  as well as drainage of bilateral pleural effusions
as well as drainage of bilateral pleural effusions
as well as drainage of bilateral pleural effusions
as well as drainage of bilateral pleural effusions
as well as drainage of bilateral pleural effusions
and treatment of CHF  as well as drainage of bilateral pleural effusions
and treatment of CHF  as well as drainage of bilateral pleural effusions
of CHF  as well as drainage of bilateral pleural effusions
who is transferred for possible pericardial effusion drainage and treatment of CHF  as well as drainage of bilateral pleural effusions
who is transferred for possible pericardial effusion drainage and treatment of CHF  as well as drainage of bilateral pleural effusions
and treatment of CHF  as well as drainage of bilateral pleural effusions
and treatment of CHF  as well as drainage of bilateral pleural effusions
of CHF  as well as drainage of bilateral pleural effusions
requiring CT  CAD  who was readmitted 0524 with ARF and lethargy  found to have a large pericardial effusion and bilateral pleural effusions  with echo showing no evidence of tamponade  who is transferred for possible pericardial effusion drainage and treatment of CHF  as well as drainage of bilateral pleural effusions
CAD  who was readmitted 0524 with ARF and lethargy  found to have a large pericardial effusion and bilateral pleural effusions  with echo showing no evidence of tamponade  who is transferred for possible pericardial effusion drainage and treatment of CHF  as well as drainage of bilateral pleural effusions
given lasix x 1 bolus 100 mg  responded somewhat and o2 sat stable in low 90 s
put on face mask  given lasix x 1 bolus 100 mg  responded somewhat and o2 sat stable in low 90 s
x 1 bolus 100 mg  responded somewhat and o2 sat stable in low 90 s
zosyn  put on face mask  given lasix x 1 bolus 100 mg  responded somewhat and o2 sat stable in low 90 s
requiring chest tube

requiring chest tube which resolved and tube was removed during admit for pacer  no evidence of PTX on most recent CXR
requiring chest tube which resolved and tube was removed during admit for pacer  no evidence of PTX on most recent CXR
requiring chest tube which resolved and tube was removed during admit for pacer  no evidence of PTX on most recent CXR
requiring chest tube which resolved and tube was removed during admit for pacer  no evidence of PTX on most recent CXR
requiring chest tube which resolved and tube was removed during admit for pacer  no evidence of PTX on most recent CXR
requiring chest tube which resolved and tube was removed during admit for pacer  no evidence of PTX on most recent CXR
at 170  prompting initiation of nitroprusside gtt


with phototherapy

once they reach six months of age
to protect the infant








cb enucleated left CMED CSRU
of in Mayotte cb enucleated CMED CSRU



and stroke risk


for anticoagulation for stroke prevention in the setting of apical akinesis
with a transition to Coumadin for anticoagulation for stroke prevention in the setting of apical akinesis
in the setting of apical akinesis
for stroke prevention in the setting of apical akinesis
she was started on heparin with a transition to Coumadin for anticoagulation for stroke prevention in the setting of apical akinesis
she was started on heparin with a transition to Coumadin for anticoagulation for stroke prevention in the setting of apical akinesis
she was started on heparin with a transition to Coumadin for anticoagulation for stroke prevention in the setting of apical akinesis
she was started on heparin with a transition to Coumadin for anticoagulation for stroke prevention in the setting of apical akinesis

in the past  she was started on Pravastatin which should give less of these side effects
which should give less of these side effects
and further evaluation of her remaining RCA lesions





once they reach six months of age
of Twin number I and progressive preterm labor

to protect the infant
admitted with lower GI bleeding


with bilateral pelvic lymph node dissection
and ileal loop urinary diversion and also radical prstatectomy with bilateral pelvic lymph node dissection
and also radical prstatectomy with bilateral pelvic lymph node dissection
sp cystectomy and ileal loop urinary diversion and also radical prstatectomy with bilateral pelvic lymph node dissection

pw BRBPR to OSH
w ileal conduit pw BRBPR to OSH
20150115
draining

to OSH
to OSH
draining
admitted with lower GI bleeding








at Greenfield Community College Community Health
and Haldol  but was responsive
but was responsive
for alcohol withdrawal
received 5 mg of Haldol  2 mg of Ativan

2 mg of Ativan

and Haldol  but was responsive
but was responsive
and Haldol  but was responsive
but was responsive


plus kidney protective effects
and Haldol  but was responsive
but was responsive
possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
IV fluids and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
to mid LAD lesion complicated by hypotension and bradycardia requiring Atropine  IV fluids and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
throughout admission
and a total occlusion of the RCA with collaterals
at home and Albuterol and Atrovent MDI s prn
by nasal cannula at home and Albuterol and Atrovent MDI s prn
s prn
and Atrovent MDI s prn
and he was then transferred to the CCU for further monitoring
Atropine  and he was then transferred to the CCU for further monitoring
dopamine  Atropine  and he was then transferred to the CCU for further monitoring
and he was then transferred to the CCU for further monitoring
Atropine  and he was then transferred to the CCU for further monitoring
dopamine  Atropine  and he was then transferred to the CCU for further monitoring

without stent placement

possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
IV fluids and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
to mid LAD lesion complicated by hypotension and bradycardia requiring Atropine  IV fluids and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
placed at the time of catheterization
and in the setting of not having a stent placed at the time of catheterization
and hematocrit drop throughout admission
with collaterals
was placed
subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
IV fluids and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
and bradycardia requiring Atropine  IV fluids and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
IV fluids and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
requiring Atropine  IV fluids and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
IV fluids and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
to mid LAD lesion complicated by hypotension and bradycardia requiring Atropine  IV fluids and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU



possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
IV fluids and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
to mid LAD lesion complicated by hypotension and bradycardia requiring Atropine  IV fluids and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
IV fluids and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
complicated by hypotension and bradycardia requiring Atropine  IV fluids and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU



throughout admission
possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
IV fluids and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
to mid LAD lesion complicated by hypotension and bradycardia requiring Atropine  IV fluids and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
IV fluids and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
to mid LAD lesion complicated by hypotension and bradycardia requiring Atropine  IV fluids and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
was initially held due to his creatinine
was placed
possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
IV fluids and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
to mid LAD lesion complicated by hypotension and bradycardia requiring Atropine  IV fluids and transient dopamine possibly secondary to vagal reaction  subsequently transferred to CCU for close monitoring  hemodynamically stable at the time of admission to the CCU
without stent placement





Benicar 20 mg QD  and Imdur 30 mg QD
Benicar 20 mg QD  and Imdur 30 mg QD
30 mg QD
20 mg QD  and Imdur 30 mg QD
Benicar 20 mg QD  and Imdur 30 mg QD
Benicar 20 mg QD  and Imdur 30 mg QD
Benicar 20 mg QD  and Imdur 30 mg QD

which could be life threatening
which could be life threatening








and ASA for her stents  the ddx for her guiac positive stools would include gastritis  gastric ulcer in addition to lower GI pathology
the ddx for her guiac positive stools would include gastritis  gastric ulcer in addition to lower GI pathology
for her stents  the ddx for her guiac positive stools would include gastritis  gastric ulcer in addition to lower GI pathology
or wheezing
was restarted
was restarted
over the course of the day with subsequent SBP s in the high 90 s low 100 s
were held 1114 and she was administered 15L NS over the course of the day with subsequent SBP s in the high 90 s low 100 s
for COPD exacerbation
and PO prednisone for COPD exacerbation
would include gastritis  gastric ulcer in addition to lower GI pathology
would include gastritis  gastric ulcer in addition to lower GI pathology
would include gastritis  gastric ulcer in addition to lower GI pathology
gastric ulcer in addition to lower GI pathology
gastric ulcer in addition to lower GI pathology
gastric ulcer in addition to lower GI pathology
in addition to lower GI pathology
in addition to lower GI pathology
in addition to lower GI pathology




and ASA for her stents  the ddx for her guiac positive stools would include gastritis  gastric ulcer in addition to lower GI pathology
the ddx for her guiac positive stools would include gastritis  gastric ulcer in addition to lower GI pathology
for her stents  the ddx for her guiac positive stools would include gastritis  gastric ulcer in addition to lower GI pathology

and ACE inhibitor and Integrilin was continued post MI for 18 hours
was continued post MI for 18 hours
and Integrilin was continued post MI for 18 hours
for good flow
complicated by no residuals requiring nitroglycerin and diltiazem for good flow
and diltiazem for good flow
remitted
remitted
for 18 hours
for 18 hours
for 18 hours
or pressure or shortness of breath  lisinopril hydrochlorothiazide 20  125 mg qd
hydrochlorothiazide 20  125 mg qd
20  125 mg qd
or shortness of breath  lisinopril hydrochlorothiazide 20  125 mg qd
hydrochlorothiazide 20  125 mg qd
20  125 mg qd
lisinopril hydrochlorothiazide 20  125 mg qd
hydrochlorothiazide 20  125 mg qd
20  125 mg qd
for good flow
complicated by no residuals requiring nitroglycerin and diltiazem for good flow
and diltiazem for good flow
was started at 325
for good flow
requiring nitroglycerin and diltiazem for good flow
and diltiazem for good flow
for good flow
complicated by no residuals requiring nitroglycerin and diltiazem for good flow
and diltiazem for good flow
